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ABSTRACT 
 
Background: The etiology of congenital heart valve defects is not well understood; little 
is known about the risk factors that contribute to the survival and mortality outcomes of 
children with these defects.  
Methods: Using data from the Texas Birth Defects Registry (TBDR) we conducted a 
retrospective cohort study of 2070 singleton infants with congenital aortic, pulmonary, or 
tricuspid valve atresia or stenosis born in Texas between January 1, 1996 and December 
31, 2007 to Hispanic, Non-Hispanic (NH) black, and NH white women. TBDR data were 
death-to-birth matched by the Texas Vital Statistics Unit for deaths between January 1, 
1996 and December 31, 2008. Using Kaplan-Meier survival estimates with log rank tests 
and Cox proportional hazards regression model hazard ratios (HR) with 95% confidence 
intervals (CI), we examined whether infant sex and maternal race/ethnicity affected early 
childhood survival or risk of mortality for children with congenital heart valve defects. 
Covariates included birth weight and gestational age, maternal age, maternal education, 
and number of co-occurring birth defects. 
Results: In children with aortic valve atresia and aortic valve stenosis, we found males 
had higher early childhood survival than females (55.0% vs. 41.5%, P=0.0451 and 91.6% 
vs. 82.5%, P=0.0492, respectively). Early childhood survival for males (94.9%) with 
pulmonary valve stenosis was slightly lower than females (97.1%, P=0.0116), and was 
ix 
 
also lower for NH black (94.1%) and Hispanic (95.3%) children than NH white children 
(97.8%, P=0.0340). After adjusting for covariates, early childhood mortality in children 
with pulmonary valve atresia with hypoplastic right ventricle was greater in NH black 
than NH white children (HR=2.93, CI 1.09-7.85, P=0.0329) and greater in NH black 
males than NH white males (HR=4.63, CI 1.12-19.19, P=0.0349). For children with 
tricuspid valve atresia, early childhood survival was lower in NH black males (35.7%) 
and Hispanic males (64.0%) than NH white males (81.0%, P=0.0269); after adjusting for 
covariates, risk for early childhood mortality was higher in NH black than NH white 
children (HR=3.39, CI 1.41-8.13, P=0.0062), and higher in NH black males than NH 
white males (HR=5.23, CI 133-20.58, P=0.0179).  
Conclusions: Our findings demonstrate there are disparities in early childhood survival 
and risk of mortality by infant sex and maternal race/ethnicity for children with 
congenital heart valve defects. These findings provide a foundation for further 
investigation to better understand why these disparities exist and what can be done to 
improve the outcomes for children with these defects. 
 
 
1 
 
 
 
 
CHAPTER 1: 
INTRODUCTION AND BACKGROUND 
 
Birth defects are a primary cause of infant mortality in developed nations 
including the United States. Some of the most prevalent and fatal birth defects are 
congenital heart defects (Cleves, Ghaffar et al. 2003). The prevalence of congenital heart 
defects worldwide is approximately 8 per 1,000 live births (Samanek, Slavik et al. 1989; 
Marelli, Mackie et al. 2007; Amorim, Pires et al. 2008; Reller, Strickland et al. 2008; 
Bernier, Stefanescu et al. 2010; Wu, Chen et al. 2010). In the United States, 
hospitalization costs associated with birth defects were greater than $2 billion in 2004, 
and congenital heart defects represented more than 50% of these costs (Russo 2007).  
Birth defect surveillance programs have been developed in many states, and data 
from these registries are useful for public health research in identifying causes for the 
development of prevention programs. Research has found differences in morbidity and 
mortality between males and females with congenital heart defects (Boneva, Botto et al. 
2001; Lary and Paulozzi 2001; Seifert, Howard et al. 2007; Nembhard, Pathak et al. 
2008; Engelfriet and Mulder 2009; Gilboa, Salemi et al. 2010). Studies have also shown 
racial disparity in prevalence, underlying cause of death, and survival for infants with 
congenital heart defects (Sadiq, Stumper et al. 1995; Boneva, Botto et al. 2001; Botto, 
Correa et al. 2001; Lary and Paulozzi 2001; Seifert, Howard et al. 2007; Nembhard, 
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Pathak et al. 2008; Almond, Thiagarajan et al. 2009; Fixler, Nembhard et al. 2010; 
Nembhard, Salemi et al. 2010; Nembhard, Wang et al. 2010; Nembhard 2011).  
Congenital heart defect research has identified disparities, some of which are 
within a subset of congenital heart defects: congenital heart valve defects. However, little 
is known about mortality among infants with atresia and stenosis of the aortic, 
pulmonary, and tricuspid valves.  
Understanding the race/ethnicity and sex differences in survival and mortality for 
infants with congenital heart valve defects can provide public health researchers and 
clinicians with information necessary to guide population health strategies and health 
care planning toward improving the lives of children and adults with these defects. 
Evaluations of potential disparity in survival probability and the risk of mortality in 
infants born with congenital heart valve defects are necessary to expand the current 
understanding of the role of race/ethnicity and sex in the complex etiology of these 
defects. Such knowledge will be useful in the development of prevention and treatment 
protocols for congenital heart valve defects. Our study evaluates race/ethnicity and sex as 
risk factors for congenital heart valve defect survival probability and risk of mortality. 
ETIOLOGY OF CONGENITAL HEART DEFECTS  
The etiology of congenital heart defects is unclear. There are numerous distinct 
congenital heart defects with various degrees of severity that contribute to the difficulty 
in clearly identifying the pathogenesis and etiology of the defects. Approximately 64% of 
congenital heart defects are isolated defects, most of the remaining cases are included 
with defects such as trisomies and syndromes (Botto, Lin et al. 2007). The cause for 
congenital heart defects can be categorized as follows: chromosomal abnormalities, 
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single gene defects, environmental factors, and family history (Thompson, McInnes et al. 
1991). Other risk factors for congenital heart defects that have been identified include any 
of the following during pregnancy: maternal diabetes, maternal alcohol consumption, 
maternal exposure to prescription or non-prescription drugs or chemicals, and mothers 
who had rubella, rheumatic fever, or viral infection such as influenza during pregnancy 
(Sadler 2000). As such, the etiology of congenital heart defects is best understood as a 
complex interaction of environmental and genetic causes.  
EMBRYOGENESIS OF THE HEART  
Most congenital heart defects originate during the formation of the structure of the 
heart – during the first six weeks of gestation. By the 15th day post conception, 
mesoderm and ectoderm cells exist that will develop into the heart. Endocardial tubes are 
formed from these cells by the 19th day, and these tubes fuse and form heart cells 
(myocytes) by the 21st day. The heart starts beating on day 22 and blood is circulating by 
day 24. During the 23rd to 28th days the heart tube folds and twists to form atria and 
ventricles. Within the next two weeks the chambers of the heart form (Sadler 2000). 
FETAL AND NEONATAL HEART DEVELOPMENT  
Before birth, oxygen in the fetus’ blood is provided by the mother. There is an 
opening between the right and left atrium, called the foramen ovale, through which blood 
flows from the right to left atrium. Blood bypasses the fetus’ lungs through a blood vessel 
that connects the aorta and pulmonary arteries (ductus arteriosus). After birth the lungs 
fill with air, thereby reducing pulmonary resistance and increasing the blood flow from 
the right atrium to the right ventricle and into the pulmonary arteries. This reduces the 
flow of blood through the foramen ovale from the right atrium to the left atrium. These 
4 
 
changes result in the closing of the foramen ovale, and separation of the circulatory 
system into left and right halves. Once the baby is breathing on its own, the ductus 
arteriosus is no longer necessary and normally closes within days after birth (Moller and 
Neal 1990). 
CONGENITAL HEART DEFECTS  
Congenital heart defects are structural heart abnormalities of the arteries and veins 
near the heart, or the valves or walls within the heart, and are present at birth. Congenital 
heart defects disrupt the normal flow of blood through the heart, causing blood flow to 
slow down, flow in the wrong direction or to the wrong place, or be blocked completely 
(Moss and Allen 2008). There are many types of congenital heart defects with varied 
degrees of severity. 
CONGENITAL HEART VALVE DEFECTS  
In a normally functioning heart the flow of blood from the body through the heart 
and back out to the body is properly regulated by the opening and closing of heart valves 
with each heartbeat, as shown in Figure 1. Defective heart valves do not fully open or 
allow blood to leak back into heart chambers. Congenital heart valve defects include, but 
are not limited to: aortic valve atresia, aortic valve stenosis, pulmonary valve atresia, 
pulmonary valve stenosis, tricuspid valve atresia, and tricuspid valve stenosis. Congenital 
heart valve atresia is a defect that results when the valve fails to develop; stenosis is a 
defect resulting from narrowing or constriction of the valve, wherein the flaps of the 
valve do not fully open to allow enough blood to flow through (Moss and Allen 2008). 
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Figure 1. Cross section of a healthy heart. (U. S. Department of Health and Human 
Services).  
 
NEED FOR THE STUDY  
For nearly 20 years, researchers have reported disparities in risk factors for 
congenital heart defects and also among congenital heart valve defects. However, not all 
of the results of previous investigations agree. Limitations of previous studies include 
limited accuracy of congenital heart defect diagnosis documentation (Strickland, Riehle-
Colarusso et al. 2008; Mangones, Manhas et al. 2009; Nembhard and Loscalzo 2009), 
and limitations of passive surveillance systems (Nembhard and Loscalzo 2009). In 
addition, previous studies did not evaluate all congenital heart valve defects individually; 
data for some defects were combined because of coding methods. 
Perhaps the inconsistencies in results of previous investigations are due to 
reporting or diagnosis errors; a study using data with confirmed diagnoses might 
demonstrate stronger associations than have been observed in other studies. Verified data 
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are now available that clarify diagnoses for atresia and stenosis defect categories that 
have historically been combined. These data could also improve misdiagnosis limitations 
of previous studies. 
Due to the variation in severity of heart valve defects, children with defects such 
as pulmonary or aortic valve stenosis might be expected to have better survival than 
children with pulmonary valve atresia (Samanek 1992; Samanek and Voriskova 1999). 
However, an evaluation of survival and mortality by sex or race/ethnicity for children 
with each specific congenital heart valve defect has not been reported. There is limited 
published information on survival probability and risk of mortality by sex or 
race/ethnicity for congenital heart valve defects. Our study determines survival and risk 
of mortality among children with congenital heart valve defects by infant sex and 
maternal race/ethnicity.  
SPECIFIC AIMS AND HYPOTHESES  
The purpose of this study was to evaluate risk factors associated with congenital 
heart valve defects in children. This study assesses whether the probability of survival or 
risk of mortality varies by infant sex or maternal race/ethnicity for each of six congenital 
heart valve defects. Two study aims with specific sub-aims and hypotheses are 
investigated. The study aims (1 and 2) intend to evaluate early childhood survival 
probability and risk of mortality for infants or children with congenital heart valve 
defects. Study sub-aims (a and b) further elucidate the evaluation of survival probability 
and risk of mortality to determine if differences exist within the study population based 
on infant sex or maternal race/ethnicity. The specific aims and hypotheses of this study 
are: 
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Aim 1  
To determine if early childhood survival probabilities vary by infant sex or 
maternal race/ethnicity in children with congenital heart valve defects. 
Sub-aim 1a 
To determine if early childhood survival probability varies by infant sex for each 
of the congenital heart valve defects. 
H0: There is no difference in early childhood survival between males and females 
for each type of congenital heart valve defect. 
Sub-aim 1b 
To determine if early childhood survival probabilities vary by maternal 
race/ethnicity stratified by infant sex for each of the congenital heart valve defects. 
H0: There is no difference in early childhood survival between Hispanic or Non-
Hispanic (NH) black infants compared to NH white infants for each type of congenital 
heart valve defect. 
Aim 2  
To determine if the risk of childhood mortality varies by infant sex or maternal 
race/ethnicity stratified by infant sex in children with congenital heart valve defects, after 
adjusting for potential confounders. 
Sub-aim 2a 
To determine if the risk of childhood mortality varies by infant sex for each of the 
congenital heart valve defects. 
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H0: There is no difference in risk of childhood mortality between males and 
females for each type of congenital heart valve defect. 
Sub-aim 2b 
To determine if the risk of childhood mortality varies by maternal race/ethnicity, 
after stratifying by infant sex, for each of the congenital heart valve defects. 
H0: There is no difference in risk of childhood mortality between Hispanics or NH 
blacks compared to NH whites for each type of congenital heart valve defect. 
FINDINGS OF THE STUDY 
The results of this study are presented in three manuscripts: the first manuscript 
presents findings for maternal race/ethnicity and infant sex risk factors for early 
childhood survival probability and risk of mortality in infants born with aortic valve 
atresia and aortic valve stenosis. The second manuscript evaluates the hypotheses for 
pulmonary valve atresia and stenosis, and the third manuscript presents findings for 
tricuspid valve atresia. This research is significant because it advances knowledge from 
previous investigations to better understand the effects of race/ethnicity and sex on early 
childhood survival and mortality among infants born with these defects. 
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CHAPTER 2: 
DISPARITIES IN SURVIVAL AND MORTALITY AMONG INFANTS WITH 
CONGENITAL AORTIC VALVE DEFECTS BY MATERNAL 
RACE/ETHNICITY AND INFANT SEX 
 
ABSTRACT  
Background:  Little is known about racial/ethnic or infant sex differences contributing to 
the survival and mortality outcomes of children with aortic valve atresia or aortic valve 
stenosis. 
Methods:  Using data from the Texas Birth Defects Registry, we conducted a 
retrospective cohort study of 519 singleton infants born to Hispanic, Non-Hispanic (NH) 
white, and NH black women in Texas between January 1, 1996 and December 31, 2007 
with congenital aortic valve atresia and stenosis. We used Kaplan-Meier survival 
estimates with log-rank tests and Cox proportional hazards regression ratios (HR) and 
95% confidence intervals (CI) to determine, after adjusting for confounders, whether 
infant sex or maternal race/ethnicity affects early childhood survival or risk of mortality 
for these children.  
Results:  For children with aortic valve atresia and aortic valve stenosis, males had 
higher early childhood survival than females (55.0% vs. 41.5%, P=0.0451 and 91.6% vs. 
82.5%, P=0.0492, respectively). After adjusting for covariates, there was no statistically 
significant differences in early childhood mortality between males and females with 
10 
 
aortic valve atresia (HR=0.89; CI 0.59-1.35; P=0.5840) or aortic valve stenosis 
(HR=0.80; CI 0.37-1.73; P=0.5748). There were no racial/ethnic differences in risk of 
early childhood mortality for children with either aortic valve atresia or aortic valve 
stenosis.  
Conclusion:  Our study found that early childhood survival in males with aortic valve 
atresia was better than survival in females with aortic valve atresia. Similarly, early 
childhood survival in males with aortic valve stenosis was better than survival in females 
with aortic valve stenosis. Our study did not identify race/ethnicity risk factors in the 
survival or risk of mortality for children with aortic valve defects. 
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INTRODUCTION  
Birth defects are a primary cause of infant mortality and contribute more than half 
of the reported hospitalization costs associated with birth defects in the United States 
(Russo 2007). In order to improve the health and survival of infants and children, public 
health researchers need to better understand risk factors associated with congenital heart 
defects so that effective prevention and treatment programs can be developed and 
implemented (Botto, Correa et al. 2001; Nembhard, Waller et al. 2001; Cleves, Ghaffar et 
al. 2003; Nembhard, Salemi et al. 2007; Nembhard, Pathak et al. 2008; Nembhard, 
Salemi et al. 2009; Fixler, Nembhard et al. 2010; Nembhard, Salemi et al. 2010). We 
present our investigation of risk factors contributing to aortic valve atresia and aortic 
valve stenosis, toward that goal. 
Aortic Valve Stenosis  
Aortic valve stenosis is the narrowing of the valve located between the left 
ventricle and the aorta, resulting in restriction of oxygen-rich blood out of the heart to the 
body. Aortic valve stenosis is an obstruction defect and is included in the category of 
noncomplex left ventricular outflow tract obstruction malformations (i.e., aortic valve 
stenosis, coarctation of the aorta, and hypoplastic left heart syndrome). It can occur with 
patent ductus arteriosus, coarctation of the aorta, non-inlet ventricular septal defect, and 
atrial septal defect, and severity varies considerably. Mild cases can be undetected in 
early life; severe cases can cause heart failure in infants. 
Table 1 provides a summary of literature findings for aortic valve defects. As 
shown in the table, some studies did not differentiate aortic valve stenosis from aortic 
valve atresia. The prevalence of aortic valve stenosis per 10,000 live births, ranges from 
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0.61 (95% CI 0.29-1.12) to 1.39 (95% CI 1.17-1.65) (Ferencz, Rubin et al. 1985; Pradat, 
Francannet et al. 2003). Racial/ethnic disparity in the prevalence of aortic valve stenosis 
has been reported. Correa-Villasenor (1991) reported an excess of aortic valve stenosis in 
whites compared to blacks (OR=3.6; 95% CI 1.7-7.6). Fixler, Pastor et al. (1993) found 
decreased risk of aortic valve stenosis in blacks than whites (blacks=0.07/1,000 live 
births; whites=0.4/1,000; p<0.005), as did Botto, Correa et al. (2001) (RR=0.38; 95% CI 
0.22-0.64). Carmichael, Shaw et al. (2004) found lower risk of aortic valve stenosis in 
foreign-born Hispanics than NH whites (RR=0.7; 95% CI 0.6-0.8). Fixler, Pastor et al. 
(1993) also found decreased risk of aortic valve stenosis in Mexican-Americans than 
whites (0.20/1,000 vs. 0.4/1,000, respectively; p<0.05). 
Aortic valve stenosis has consistently been found higher in males than females: 
male to female ratio=2.41 (95% CI 1.84-3.25) (Pradat, Francannet et al. 2003); RR=2.52 
(95% CI 1.61-3.75) (Forrester and Merz 2004); PR=2.71 (95% CI 1.70-4.31) (McBride, 
Marengo et al. 2005); RR=1.51 (95% CI 1.11-2.07) (Lary and Paulozzi 2001); and boy to 
girl ratio=1.95:1 (Samanek 1994). 
Other studies have reported disparities in aortic valve defects, but did not study 
aortic valve atresia and stenosis separately. Lubinsky (1997) reported more aortic valve 
anomalies in males (76%) than females (24%). One study of data for 9,352 singleton 
infants in Florida’s passive surveillance birth defects registry found that aortic valve 
atresia/stenosis prevalence disparity was only statistically significant for male infants, 
(RR=0.34, 95% CI 0.13-0.94) for black males compared to white males; and (RR=0.32, 
95% CI 0.12-0.89) for Hispanic males compared to white males (Nembhard, Wang et al. 
2010). Another study using these data found NH black and Hispanic infants had lower 
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prevalence rates of aortic valve atresia/stenosis than NH white infants: (RR=0.46; 95% 
CI 0.24-0.89) for NH blacks, and (RR=0.53; 95% CI 0.28-0.97) for Hispanics 
(Nembhard, Salemi et al. 2010). 
Survival during the first year of life of infants born with aortic valve stenosis is 
around 90% (Samanek 1992; Samanek and Voriskova 1999). There are no reported data 
for mortality or survival that differentiate by sex or race/ethnicity. 
Aortic Valve Atresia  
Aortic valve atresia is the absence of the aortic valve, prohibiting blood flow from 
the heart to the body. Babies with aortic valve atresia survive only when patent ductus 
arteriosus persists. Aortic valve atresia can be associated with hypoplastic left heart 
syndrome, a complex condition characterized by an undeveloped left side of the heart, 
including the aorta, left ventricle (a defect called hypoplastic left ventricle), and mitral 
valve (defects referred to as mitral valve atresia or mitral valve stenosis). 
Although some studies have findings for aortic valve stenosis and aortic valve 
atresia/stenosis, there is a lack of information on disparity by sex or race/ethnicity 
(Table 1).   
METHODS  
Study Design and Data Source  
We conducted a retrospective cohort study of 219 infants with congenital aortic 
valve atresia and 300 infants with aortic valve stenosis born in Texas between January 1, 
1996 and December 31, 2007. Data was obtained from the Texas Birth Defects Registry 
(TBDR), which is maintained by the Birth Defects Epidemiology and Surveillance 
Branch of the Texas Department of State Health Services. In the TBDR population-based 
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active surveillance system TBDR personnel review medical records to identify infants 
diagnosed within the first year after birth with structural and chromosomal birth defects. 
The TBDR surveillance began in 1995, and since 1999 data have been collected for all 
births in the state of Texas. TBDR data are death-to-birth matched by the Texas Vital 
Statistics Unit using decedent name, date of death and date of birth, mother’s first and 
maiden and/or current last names.  
The TBDR utilizes six-digit birth defect coding that has evolved through British 
Pediatric Association (BPA) extension of the International Classification of Disease, 
ninth revision clinical modification diagnostic codes (ICD-9 codes). Our study used data 
coded according to the June 29, 2007 revision of TBDR’s BPA coding system.  
Study Population  
The study population included all live-born singleton infants with aortic valve 
atresia or aortic valve stenosis (BPA Codes 746.480 and 746.300) born in Texas between 
January 1, 1996 and December 31, 2007 to NH white, NH black, or Hispanic women of 
any age. Aortic valve atresia and aortic valve stenosis cases with co-occurring heart 
defects (BPA Codes 745.000 through 747.490) were considered for inclusion in our study 
(Appendix A). However, cases associated with complex defects such as trisomies or 
syndromes (except for hypoplastic left heart syndrome) were excluded from our study. 
All cases were reviewed by a pediatric cardiologist, Dr. David E. Fixler, M.D., and aortic 
valve atresia cases were included only if at least one of the following heart defects was 
co-occurring: hypoplastic left heart syndrome (BPA Code 746.700), mitral valve stenosis 
(BPA Code 746.500), mitral valve atresia (BPA Code 746.505), or hypoplastic left 
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ventricle (BPA Code 746.881). Aortic valve stenosis cases were selected based on review 
of these cases and their co-occurring heart defects.  
Covariates  
We used infant and maternal covariate information obtained by the TBDR from 
birth certificate and medical records. We included infant sex, and maternal race/ethnicity 
based on maternal self-report. Gestational age categorized as term (≥37 completed 
weeks) or pre-term (<37 weeks) was included; gestational age was based on last 
menstrual period or clinical estimate of gestation from medical records was substituted 
when last menstrual period data were missing. Consistent with published literature, we 
included birth weight categorized as normal (≥2500 grams), low (1500-2499 grams), or 
very low (<1500 grams), as recorded on birth certificates (CDC 1990; Alexander, Kogan 
et al. 2003; Nembhard 2011). Also consistent with literature, gestational age and birth 
weight were included as a combination variable with six categories: <37 weeks and 
<1500 grams; <37 weeks and 1500-2499 grams; <37 weeks and ≥2500 grams; ≥37 weeks 
and <1500 grams; ≥37 weeks and 1500-2499 grams; and ≥37 weeks and ≥2500 grams 
(Bol, Collins et al. 2006; Nembhard 2011). Maternal age categorized as <20 years, 20-29 
years, 30-39 years, and 40+ years and maternal education categorized as high school (12 
years), <high school, or >high school were also included. Number of co-occurring birth 
defects was also included in the analyses as a continuous variable. 
Data Analysis  
Descriptive statistics were calculated for main study variables and covariates. We 
calculated survival time using date of birth and date of death for deceased infants. When 
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TBDR data did not have a date of death recorded, infants were censored at the end of the 
study period, December 31, 2008.  
Early childhood survival was estimated for children with each defect using the 
Kaplan-Meier method. Kaplan-Meier survival curves were computed to compare survival 
estimates by infant sex, and maternal race/ethnicity, and tested the difference between the 
curves using the log-rank test.  
Unadjusted and adjusted hazard ratios were calculated for mortality using Cox 
proportional hazard regression models. The adjusted hazard ratios were computed using a 
final regression model developed by backward selection method, removing variables with 
less than 10% effect on the hazard ratio. The models for infant sex and maternal 
race/ethnicity stratified by sex used females and NH whites as the reference groups. The 
proportional hazards assumption was tested to ensure the assumption was met; we 
inspected the proportionality by including time-dependent covariates in the model and 
testing for their significance. Variables included in the final model were: maternal age, 
maternal education, birth weight/gestational age, and number of defects. Although not all 
variables had a major effect on the adjusted hazard ratios (i.e., changing the hazard ratio 
by 10% or more), all of the variables included in the final model are biologically 
important based on published literature. Results were considered statistically significant 
if the 95% confidence interval excluded 1 or P<0.05. Calculations were performed using 
SAS 9.2 for Kaplan-Meier survival estimates and Cox proportional hazards regression 
models, and Stata Release 12 for Kaplan-Meier survival plots. 
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Protection of Human Subjects  
The study was conducted with the approval of the University of South Florida 
Institutional Review Board (IRB), and the Texas Department of State Health Services.  
Power and Sample Size  
The formula used to estimate power for this study is an extension of Schoenfeld’s 
sample-size formula for the proportional-hazards regression model, solved for power (1-
β) (Hipwell, Strachan et al. 2000; Shechter, Sharir et al. 2000): 
 
(z1-α/2 + z1-β)
2
  
N   =   _____________________ 
   P (1-R
2) σ2 B2 
 
Where N is the sample size; z1-α/2 and z1-β are standard normal deviates at a two-
sided significance level α and power (1-β); P is the overall event rate or proportion of 
non-censored participants; R
2 is the effect size of covariates on the variable of interest; σ 
is the standard deviation of the variable of interest; and B is the effect size (log of the 
hazard ratio). 
We calculated the power to detect hazard ratios of 1.5 and 3.0; the significance 
level, alpha, for our study was 0.05. Since our associations indicate risk or protective 
exposures, two sided hypotheses were tested. Standard deviation values of 0.5 and 0.7 
were used to show a range of possibilities; the influence of covariates on the outcome, R
2
 
was estimated at 0.15. Based on the study data, estimates of study power were calculated 
based on three potential scenarios: 1) an event (death) rate of 5%, 2) an event rate of 
10%, and 3) an event rate of 40%.  
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The results of these calculations are presented in Appendix B. Since our study 
size was fairly small for some of our stratified groups, our ability to observe statistically 
significant results may be limited.  
RESULTS  
Aortic Valve Atresia  
Descriptive statistics for infants born with aortic valve atresia are provided in 
Table 2. The total number of aortic valve atresia cases in our study was 219 and included 
89 NH white, 23 NH black, and 107 Hispanic children. Of these, 112 (51.1%) children 
were alive at the end of our study and 107 (48.9%) were deceased. More than half 
(52.2%) of the NH black children with aortic valve atresia died during the study period 
while fewer than half of the Hispanic (48.6%) or NH white (48.3%) children died. 
Approximately 80.4% of surviving children and 71.0% of deceased children were born 
full term (≥37 weeks) and at normal birth weight (≥2500 grams). There were 
considerably more males (62.6%) than females (37.4%) with aortic valve atresia.  
Survival and Risk of Childhood Mortality by Infant Sex  
Kaplan-Meier estimates, hazard ratios, and 95% confidence intervals are 
presented in Table 3. Early childhood survival for males (55.0%) with aortic valve atresia 
was significantly higher than for females (41.5%, P = 0.0451). After adjusting for 
covariates, there was no statistically significant difference in early childhood mortality 
between males and females with aortic valve atresia (HR 0.89; 95% CI 0.59-1.35; 
P=0.584).  
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Survival by Maternal Race/Ethnicity and Infant Sex  
Kaplan-Meier estimates for children with aortic valve atresia are presented in 
Table 4, and survival curves are presented in Figure 2. The estimated survival for 
children was not significantly different for NH white (50.3%), NH black (47.4%), and 
Hispanic (50.2%) children (P=0.9956); NH black males (35.7%), NH white males 
(56.6%), and Hispanic (58.2%) males (P=0.3707); or NH black females (64.8%), NH 
white females (39.4%), and Hispanic (38.1%) females (P=0.3160).  
Risk of Childhood Mortality by Maternal Race/Ethnicity and Infant Sex 
Hazard ratios and CI for early childhood mortality in children with aortic valve 
atresia are presented in Table 5. After adjusting for covariates, NH black (HR 1.13; CI 
0.58-2.22; P=0.7241) and Hispanic (HR 0.88; CI 0.57-1.38; P=0.5846) infants born with 
aortic valve atresia do not have significantly different early childhood mortality than NH 
white infants. Early childhood mortality was not statistically different in NH black 
females (HR 0.33; CI 0.09-1.18; P=0.0886) or Hispanic females (HR 0.95; CI 0.47-1.94; 
P=0.8886) compared to NH white females. NH black males (HR 1.95; CI 0.83-4.59; 
P=0.1283) or Hispanic males (HR 0.50; CI 0.50-1.73; P=0.8604), did not have 
statistically different early childhood mortality compared to NH white males.  
Aortic Valve Stenosis  
Descriptive statistics for infants born with aortic valve stenosis are provided in 
Table 6. The study included 300 aortic valve stenosis cases: 145 NH white, 14 NH black, 
and 141 Hispanic children. Of these, 268 (89.3%) were alive at the end of our study and 
32 (10.7%) were deceased. Approximately 77.6% of surviving children and 56.3% of 
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deceased children were born full term (≥37 weeks) and at normal birth weight (≥2500 
grams). There were considerably more males (68.7%) than females (31.3%) with aortic 
valve stenosis; however, of the deceased children approximately 46.9% were female.  
Survival and Risk of Childhood Mortality by Infant Sex  
Kaplan-Meier estimates, hazard ratios, and 95% confidence intervals are 
presented in Table 3. Early childhood survival for males (91.6%) with aortic valve 
stenosis was significantly higher than for females (82.5%, P=0.0492). After adjusting for 
covariates, there was no statistically significant difference in early childhood mortality 
between males and females with aortic valve stenosis (HR 0.80; 95% CI 0.37-1.73; 
P=0.5748).  
Survival by Maternal Race/Ethnicity and Infant Sex  
The Kaplan-Meier estimates for children with aortic valve stenosis are presented 
in Table 4, and Kaplan-Meier survival curves are presented in Figure 3. The estimated 
survival for children was not significantly different for NH white (89.4%), NH black 
(92.9%), and Hispanic (87.82%) children (P=0.8852); NH white males (91.9%) and 
Hispanic (90.5%) males (P=0.6236); or NH black females (83.3%), NH white females 
(83.3%), and Hispanic (81.6%) females (P=0.9625).  
Risk of Childhood Mortality by Maternal Race/Ethnicity and Infant Sex 
The Cox proportional hazards regression model results for children with aortic 
valve stenosis adjusted for covariates are presented in Table 5. NH black (HR 0.40; CI 
0.05-3.23; P=0.386) and Hispanic (HR 0.51; CI 0.20-1.28; P=0.1493) infants born with 
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aortic valve stenosis do not have significantly lower risk for early childhood mortality 
than NH white infants.  
Cox proportional hazards model results by maternal race/ethnicity stratified by 
infant sex and adjusted for covariates are presented in Table 5. Risk of early childhood 
mortality was not statistically different in NH black females (HR 0.94; CI 0.09-9.75; 
P=0.9608) or Hispanic females (HR 0.25; CI 0.06-1.14; P=0.0728) compared to NH 
white females, or NH black males (HR undefined) and Hispanic males (HR 0.91; CI 
0.26-3.22; P=0.8843) compared to NH white males with aortic valve stenosis. 
DISCUSSION  
We investigated 219 cases of aortic valve atresia and 300 cases of aortic valve 
stenosis and for each defect we found males had higher early childhood survival than 
females. After adjusting for covariates, we did not observe statistically significant 
differences in early childhood mortality. 
Aortic valve atresia has not previously been studied as a defect isolated from 
aortic valve stenosis. Aortic valve atresia inclusion criteria for our study considered cases 
only if at least one of the following defects was co-occurring: hypoplastic left heart 
syndrome, mitral valve stenosis, mitral valve atresia, or hypoplastic left ventricle. As 
such, we did not investigate aortic valve atresia as an isolated defect since clinically this 
defect does not occur unless it is part of other malformations of the heart. For this reason, 
our results for aortic valve atresia may not be directly comparable to findings of previous 
studies. 
Previous investigations have reported 1-year survival probabilities of 91 % (CI 
89-92) (Samanek 1992) and 90% (CI 87-93) (Samanek and Voriskova 1999) for aortic 
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valve stenosis; our Kaplan-Meier survival curves for males do not conflict with these 
findings, but females’ survival in the first year are below 90%, particularly for NH black 
and NH white females in our study.  
We found infant sex differences in the pattern of survival for our study period. 
However, when considering the confounding influence of covariates, we did not see 
differences in the risk of early childhood mortality. The variables with most influence on 
the final regression model were birth weight/gestational age and number of co-occurring 
defects.  
Sex disparities in early childhood survival indicate genetics may influence 
survival outcomes. Our study did not evaluate paternal variables such as paternal 
race/ethnicity. We also did not investigate maternal or paternal environmental factors, 
family history of congenital heart valve defects, or severity of defects. The possibility 
exists that there are unidentified factors that explain the sex disparities in early childhood 
survival for children with congenital aortic valve defects.  
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CHAPTER 3: 
DISPARITIES IN SURVIVAL AND MORTALITY AMONG INFANTS WITH 
CONGENITAL PULMONARY VALVE DEFECTS BY MATERNAL 
RACE/ETHNICITY AND INFANT SEX  
 
ABSTRACT  
Background:  Little is known about racial/ethnic or infant sex differences contributing to 
the survival and mortality outcomes of children with pulmonary valve atresia or 
pulmonary valve stenosis. 
Methods:  We conducted a retrospective cohort study of 1561 singleton infants born to 
Hispanic, Non-Hispanic (NH) white, and NH black women in Texas between January 1, 
1996 and December 31, 2007 with congenital pulmonary valve defects. Using data 
collected by the Texas Birth Defects Registry, we calculated Kaplan-Meier survival 
estimates, Cox-proportional hazards regression hazard ratios (HR) and 95% confidence 
intervals (CI) to determine, after adjusting for confounders, whether infant sex or 
maternal race/ethnicity affects early childhood survival or risk of mortality for these 
children. 
Results:  Early childhood mortality was greater in NH black than NH white children with 
pulmonary valve atresia and hypoplastic right ventricle (HRV) (HR=2.93; CI 1.09-7.85; 
P=0.0329); NH black males were at much greater risk of early childhood mortality than 
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NH white males (HR=4.63; CI 1.12-19.19; P=0.0349) with pulmonary valve atresia and 
HRV. Early childhood survival estimates for males (94.9%) with pulmonary valve 
stenosis were slightly lower (P=0.0116) than females (97.1%), and early childhood 
survival for NH black children (94.1%) and Hispanic (95.3%) children were lower than 
NH white (97.8%) children with pulmonary valve stenosis (P=0.0340).  
Conclusion:  We observed infant sex and racial/ethnic disparities in survival and early 
childhood mortality for infants born with pulmonary valve atresia with HRV and those 
without HRV.  
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INTRODUCTION  
Birth defects are a primary cause of infant mortality and contribute more than half 
of the reported hospitalization costs associated with birth defects in the United States 
(Russo 2007). In order to improve the health and survival of infants and children, public 
health researchers need to better understand risk factors associated with congenital heart 
defects so that effective prevention and treatment programs can be developed and 
implemented (Botto, Correa et al. 2001; Nembhard, Waller et al. 2001; Cleves, Ghaffar et 
al. 2003; Nembhard, Salemi et al. 2007; Nembhard, Pathak et al. 2008; Nembhard, 
Salemi et al. 2009; Fixler, Nembhard et al. 2010; Nembhard, Salemi et al. 2010). We 
present our investigation of infant sex and maternal race/ethnicity risk factors 
contributing to early childhood survival and risk of mortality for infants born with 
pulmonary valve atresia or pulmonary valve stenosis. 
Pulmonary Valve Stenosis  
Pulmonary valve stenosis is a narrowing of the valve located between the right 
ventricle and the pulmonary artery, restricting blood flow from the heart to the lungs. It is 
an obstruction defect included in the broader category of right ventricular outflow tract 
obstruction (RVOTO). Pulmonary valve stenosis is relatively common, and accounts for 
approximately 10 percent of all children with congenital heart defects. Table 7 provides a 
summary of study findings for pulmonary valve defects. As shown in the table, some 
studies did not differentiate pulmonary valve stenosis from pulmonary valve atresia. 
There are varied degrees of severity for pulmonary valve stenosis. In mild cases, 
pulmonary valve stenosis usually does not require treatment, but in severe cases, infants 
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are cyanotic at birth and eventually develop increasingly severe obstruction as he/she 
grows. 
Pulmonary valve stenosis is a major component of another complex congenital 
heart defect – tetralogy of Fallot. There is a potential genetic contribution to risk of 
pulmonary valve stenosis since familial occurrence has been reported and the defect is 
associated with Algille syndrome and Noonan’s syndrome (Moller and Neal 1990).  
The reported prevalence of pulmonary valve stenosis per 10,000 live births ranges 
from 1.10 (95% CI 0.89-1.34) to 10.1 (95% CI 9.3-10.9) (Ferencz, Rubin et al. 1985; 
Pradat, Francannet et al. 2003; Dadvand, Rankin et al. 2009) (Table 7). Racial/ethnic 
disparity in pulmonary valve stenosis has been reported. Fewer cases of pulmonary valve 
stenosis have been reported for whites compared to blacks (Odds Ratio=0.6; 95% CI 0.4-
0.8) (Correa-Villasenor, McCarter et al. 1991). Nembhard, Wang et al. (2010) found 
increased prevalence of pulmonary valve atresia/stenosis in NH black males, compared to 
NH white males (Rate Ratio (RR)=1.72; 95% CI 1.30-2.29) and in NH black females, 
compared to NH white females (RR=1.64; 95% CI 1.22-2.19). Another study found that 
NH black infants had a higher prevalence rate of pulmonary valve atresia/stenosis than 
NH white infants (RR=1.68; 95% CI 1.38-2.05) (Nembhard, Salemi et al. 2010). 
However, since data for pulmonary valve atresia and stenosis were combined in these 
studies. 
Survival of infants born with pulmonary valve stenosis is high. It was reported as 
having the highest first year survival of congenital heart defects studied in Arkansas birth 
defects registry data for 1993 to 1998 (Cleves, Ghaffar et al. 2003). First-year survival for 
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infants born with pulmonary valve stenosis is about 96 to 97% (Samanek 1992; Samanek 
and Voriskova 1999). 
A study using data from the Texas Birth Defects Registry (TBDR) found higher 
risk of early childhood mortality in NH black (HR 2.60; CI 1.32-5.12; P=0.0058) and 
Hispanic (HR 1.76; CI 1.06-2.91; P=0.0290) children compared to NH white children 
with pulmonary valve atresia without ventricular septal defect (Nembhard, Salemi et al. 
2011). There are no reported significant disparities for the risk of mortality for infants 
with congenital pulmonary valve stenosis. 
Pulmonary Valve Atresia  
Pulmonary valve atresia is the absence of the pulmonary valve. Babies with 
pulmonary valve atresia can survive if the ductus arteriosus does not close, which is 
called patent ductus arteriosus. This defect sometimes occurs in conjunction with the 
underdevelopment of the right ventricle, a heart defect referred to as hypoplasia of the 
right ventricle. In other cases, hypoplasia of the right ventricle is absent. Pulmonary valve 
atresia is commonly present in conjunction with another congenital heart defect, 
ventricular septal defect, (an opening in the wall between the two heart ventricles). 
Pulmonary valve atresia with intact ventricular septum is uncommon; it can be diagnosed 
during the fetal stage (in utero) when pregnancy termination is an option. Pulmonary 
valve atresia is also associated with another congenital heart defect, Ebstein’s anomaly. 
Pulmonary valve atresia is also associated with DiGeorge syndrome, a genetic mutation 
disease. Table 7 provides a summary of study findings for pulmonary valve defects. As 
shown in the table, some studies did not differentiate pulmonary valve stenosis from 
pulmonary valve atresia. 
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The prevalence of pulmonary valve atresia per 10,000 live births ranges from 0.73 
(95% CI 0.55-0.91) to 5.8 (Ferencz, Rubin et al. 1985; Pradat, Francannet et al. 2003). 
Racial/ethnic disparity in pulmonary valve atresia has been reported. An excess of 
pulmonary valve atresia was found in whites compared to blacks (Odds Ratio=2.5; 95% 
CI 1.0-6.1) (Correa-Villasenor, McCarter et al. 1991). Also, as discussed for pulmonary 
valve stenosis, Nembhard, Wang et al. (2010) and Nembhard, Salemi et al. (2010) found 
racial/ethnic disparity in prevalence of pulmonary valve atresia/stenosis as a combined 
defect category. 
Survival of infants born with pulmonary valve atresia is low; the 1-year survival 
for pulmonary valve atresia has been reported by Samanek and Voriskova (1999) as 19% 
(95% CI 8-30) and Samanek (1992) as 30% (95% CI 12-47). There are no reported data 
for survival by infant sex or maternal race/ethnicity or data on the risk of mortality for 
pulmonary valve atresia. 
METHODS  
Study Design and Data Source  
We conducted a retrospective cohort study of 238 infants with congenital 
pulmonary valve atresia and 1,323 infants with pulmonary valve stenosis born in Texas 
between January 1, 1996 and December 31, 2008. The source of data used in our study is 
the Texas Birth Defects Registry (TBDR), maintained by the Birth Defects Epidemiology 
and Surveillance Branch of the Texas Department of State Health Services. The TBDR 
includes population-based data obtained by active surveillance; TBDR personnel review 
medical records to identify infants diagnosed within the first year after birth with 
structural and chromosomal birth defects. The TBDR surveillance began in 1995, and 
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since 1999 data have been collected for all births in the state of Texas. TBDR data are 
death-to-birth matched by the Texas Vital Statistics Unit using decedent name, date of 
death and date of birth, mother’s first and maiden and/or current last names.  
The TBDR utilizes six-digit birth defect coding that has evolved through British 
Pediatric Association (BPA) extension of the International Classification of Disease, 
ninth revision clinical modification diagnostic codes (ICD-9 codes).  
Study Population  
The study population included all live-born singleton infants with pulmonary 
valve atresia or pulmonary valve stenosis (BPA Codes 746.000 and 746.010) born in 
Texas between January 1, 1996 and December 31, 2008 to NH white, NH black, or 
Hispanic women of any age. Pulmonary valve atresia and pulmonary valve stenosis cases 
with co-occurring heart defects (BPA Codes 745.000 through 747.490) were considered 
for inclusion in our study (Appendix A). However, cases associated with complex defects 
such as trisomies or syndromes were excluded. For example, pulmonary valve atresia 
associated with Ebstein’s anomaly or DiGeorge syndrome and pulmonary valve stenosis 
associated tetralogy of Fallot, Algille syndrome, or Noonan’s syndrome were not 
included in our study. 
All cases were reviewed by a pediatric cardiologist (Dr. David Fixler, M.D.). 
Pulmonary valve atresia cases were included and evaluated as two separate conditions: if 
pulmonary valve atresia was co-occurring with hypoplastic right ventricle (HRV) (BPA 
Code 746.882) and if pulmonary valve atresia was not accompanied by HRV. We did not 
include or exclude cases of pulmonary valve atresia based on the presence or absence of 
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ventricular septal defect. Pulmonary valve stenosis cases were selected based on review 
of these cases and their co-occurring heart defects.  
Covariates  
We used infant and maternal covariate information obtained by the TBDR from 
birth certificate and medical records. We included infant sex and maternal race/ethnicity 
based on maternal self-report. Gestational age categorized as term (≥37 completed 
weeks) or pre-term (<37 weeks) was included; gestational age was based on last 
menstrual period or clinical estimate of gestation from medical records was substituted 
when last menstrual period data were missing. Consistent with published literature, we 
included birth weight categorized as normal (≥2500 grams), low (1500-2499 grams), or 
very low (<1500 grams), as recorded on birth certificates (CDC 1990; Alexander, Kogan 
et al. 2003; Nembhard 2011). Also consistent with literature, gestational age and birth 
weight were included as a combination variable with six categories: <37 weeks and 
<1500 grams; <37 weeks and 1500-2499 grams; <37 weeks and ≥2500 grams; ≥37 weeks 
and <1500 grams; ≥37 weeks and 1500-2499 grams; and ≥37 weeks and ≥2500 grams 
(Bol, Collins et al. 2006; Nembhard 2011). Maternal age categorized as <20 years, 20-29 
years, 30-39 years, and 40+ years and maternal education categorized as high school (12 
years), <high school, or >high school were also included. Number of co-occurring birth 
defects was also included in the analysis as a continuous variable. 
Data Analysis  
Descriptive statistics were calculated for main study variables and covariates. We 
calculated survival time using date of birth and date of death for deceased infants. When 
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TBDR data did not have a date of death recorded, infants were censored at the end of the 
study period, December 31, 2008.  
Early childhood survival was estimated for children with each defect using the 
Kaplan-Meier method. Kaplan-Meier survival curves were computed to compare survival 
estimates by infant sex, and maternal race/ethnicity, and tested the difference between the 
curves using the log-rank test.  
Unadjusted and adjusted hazard ratios were calculated for mortality using Cox 
proportional hazard regression models. The adjusted hazard ratios were computed using a 
final regression model developed by backward selection method, removing variables with 
less than 10% effect on the hazard ratio. The models for infant sex and maternal 
race/ethnicity stratified by sex used females and NH whites as the reference groups. The 
proportional hazards assumption was tested to ensure the assumption was met; we 
inspected the proportionality by including time-dependent covariates in the model and 
testing for their significance. Variables included in the final model were: maternal age, 
maternal education, birth weight/gestational age, and number of defects. Although not all 
variables had a major effect on the adjusted hazard ratios (i.e., changing the hazard ratio 
by 10% or more), all of the variables included in the final model are biologically 
important based on published literature. Results were considered statistically significant 
if the 95% confidence interval excluded 1 or P<0.05. Calculations were performed using 
the SAS 9.2 for Kaplan-Meier survival estimates and Cox proportional hazards regression 
models, and Stata Release 12 for Kaplan-Meier survival plots. 
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Protection of Human Subjects  
The study was conducted with the approval of the University of South Florida 
Institutional Review Board (IRB) and the Texas Department of State Health Services. 
Power and Sample Size  
The formula used to estimate power for this study is an extension of Schoenfeld’s 
sample-size formula for the proportional-hazards regression model, solved for power (1-
β) (Hipwell, Strachan et al. 2000; Shechter, Sharir et al. 2000): 
 
(z1-α/2 + z1-β)
2
  
N   =   _____________________ 
   P (1-R
2) σ2 B2 
 
Where N is the sample size; z1-α/2 and z1-β are standard normal deviates at a two-
sided significance level α and power (1-β); P is the overall event rate or proportion of 
non-censored participants; R
2 is the effect size of covariates on the variable of interest; σ 
is the standard deviation of the variable of interest; and B is the effect size (log of the 
hazard ratio). 
We calculated the power to detect hazard ratios of 1.5 and 3.0; the significance 
level, alpha, for our study was 0.05. Since our associations indicate risk or protective 
exposures, two sided hypotheses were tested. Standard deviation values of 0.5 and 0.7 
were used to show a range of possibilities; the influence of covariates on the outcome, R
2
 
was estimated at 0.15. Based on the study data, estimates of study power were calculated 
based on three potential scenarios: 1) an event (death) rate of 5%, 2) an event rate of 
10%, and 3) an event rate of 40%.  
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The results of these calculations are presented in Appendix B. Since our study 
size was fairly small for some of our stratified groups, our ability to observe statistically 
significant results may be limited.  
RESULTS  
Pulmonary Valve Atresia with HRV  
Descriptive statistics for infants born with pulmonary valve atresia with HRV are 
provided in Table 8. The total number of cases in our study was 124 and included 40 NH 
white, 16 NH black, and 68 Hispanic children. Of these, 83 (66.9%) children were alive 
at the end of our study and 41 (33.1%) were deceased. Approximately 79.5% of surviving 
children and 56.1% of deceased children were born full term (≥37 weeks) and at normal 
birth weight (≥2500 grams). There were more males (55.6%) than females (44.4%) with 
pulmonary valve atresia and HRV.  
Survival and Risk of Childhood Mortality by Infant Sex  
Kaplan-Meier estimates, hazard ratios, and 95% CI are presented in Table 9. 
Early childhood survival for males (68.9%) with pulmonary valve atresia and HRV was 
not different from females (62.3%) (P = 0.4499), nor was there statistically significant 
difference in early childhood mortality between males and females with pulmonary valve 
atresia and HRV (HR 1.19; 95% CI 0.59-2.40; P=0.6333) after adjusting for potential 
confounders.  
Survival by Maternal Race/Ethnicity and Infant Sex  
Kaplan-Meier estimates for children with pulmonary valve atresia and HRV are 
presented in Table 10, and survival curves are presented in Figure 4. The estimated 
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survival for NH black children (43.8%) was not significantly lower than NH white 
(77.5%) and Hispanic (64.2%) children (P=0.1081). There were not statistically 
significant differences in estimated survival for NH black males (44.4%) compared to 
NH white males (75.0%) and Hispanic males (70.6%, P=0.2019), or for NH black 
females (42.9%) and Hispanic females (57.3%) compared to NH white females (81.3%, 
P=0.2547).  
Risk of Childhood Mortality by Maternal Race/Ethnicity and Infant Sex 
The Cox proportional hazards regression model results for risk of mortality in 
children with pulmonary valve atresia and HRV, comparing NH blacks to the reference 
group of NH whites adjusted for potential confounders and results for the model stratified 
by sex are presented in Table 11. Based on the results of our study, NH black children 
with pulmonary valve atresia and HRV have 193% higher risk of early childhood 
mortality than NH white children with the same defect (HR 2.93; CI 1.09-7.85; 
P=0.0329). Also shown in Table 11, this risk was due to the 363% higher risk of early 
childhood mortality in NH black male children compared to NH white males (HR 4.63; 
CI 1.12-19.18; P=0.0349), since NH black females with this defect do not have 
significantly higher risk of early childhood mortality than NH white children (HR 1.42; 
CI 0.27-7.57; P=0.6794).  
The Cox proportional hazards model results by maternal race/ethnicity and by 
maternal race/ethnicity stratified by sex for children with pulmonary valve atresia and 
HRV, as presented in Table 11, do not show significant differences in risk of childhood 
mortality in Hispanic children (HR 1.04; CI 0.44-2.44; P=0.9258), Hispanic females (HR 
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0.88; CI 0.21-3.76; P=0.86), or Hispanic males (HR 1.17; CI 0.36-3.83; P=0.7974), 
compared to NH whites.  
Pulmonary Valve Atresia without HRV  
Descriptive statistics for characteristics of infants with pulmonary valve atresia 
without HRV and their birth mothers are provided in Table 12. The total number of cases 
in our study was 114 and included 41 NH white, 15 NH black, and 58 Hispanic children. 
Of these, 60 (52.6%) children were alive at the end of our study and 54 (47.4%) were 
deceased. Approximately 75% of surviving children and 63% of deceased children were 
born full term and at normal birth weight. There were approximately as many males 
(50.9%) as females (49.1%) that had pulmonary valve atresia without HRV. 
Survival and Risk of Childhood Mortality by Infant Sex  
Kaplan-Meier estimates, hazard ratios and 95% CI are presented in Table 9. Early 
childhood survival for males (60.3%) with pulmonary valve atresia without HRV was 
higher than females (44.3%), but not significantly (P = 0.1019). After adjusting for 
covariates, there was no statistically significant difference in early childhood mortality 
between males and females with pulmonary valve atresia without HRV (HR 0.77; 95% 
CI 0.41-1.46; P=0.4267).  
Survival by Maternal Race/Ethnicity and Infant Sex  
Kaplan-Meier estimates for children with pulmonary valve atresia without HRV 
are presented in Table 10, and survival curves are presented in Figure 5. The estimated 
survival was not significantly different for NH black children (40.0%) and Hispanic 
(48.3%) children compared to NH white children (62.4%, P=0.1767), NH black males 
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(28.6%) and Hispanic males (57.1%) compared to NH white males (73.9%, P=0.1052), or 
NH black females (50.0%) and Hispanic females (40.0%) compared to NH white females 
(49.4%, P=0.5851).  
Risk of Childhood Mortality by Maternal Race/Ethnicity and Infant Sex 
Hazard ratios and CI for early childhood mortality in children with pulmonary 
valve atresia without HRV are presented in Table 11. There was no statistical difference 
in early childhood mortality in NH black (HR 2.32; CI 0.93-5.83; P=0.0729) and 
Hispanic (HR 1.66; CI 0.80-3.45; P=0.1781) infants born with pulmonary valve atresia 
without HRV compared to NH white infants. Stratifying by sex and adjusting for 
covariates did not result in statistically different early childhood mortality in NH black 
females (HR 1.75; CI 0.42-7.27; P=0.4393) or Hispanic females (HR 1.45; CI 0.57-3.68; 
P=0.4385) compared to NH white females, or NH black males (HR 3.87; CI 0.96-15.57; 
P=0.057) and Hispanic males (HR 2.68; CI 0.72-10.01; P=0.1416) compared to NH white 
males. 
Pulmonary Valve Stenosis  
Descriptive statistics for infants born with pulmonary valve stenosis are provided 
in Table 13. The total number of cases in our study was 1323 and included 517 NH 
white, 169 NH black, and 637 Hispanic children. Of these, 1275 (96.4%) children were 
alive at the end of our study and 48 (3.6%) were deceased. Approximately 70% of 
surviving children and 39.6% of deceased children were born full term (≥37 weeks) and 
at normal birth weight (≥2500 grams); however, approximately 47.9% of deceased 
children were born pre-term (<37 weeks) and at low (1500-2499) or very low (<1500 
grams) birth weight. There were fewer males (44.9%) than females (55.1%) that had 
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pulmonary valve stenosis; however, approximately 62.5% of the deceased cases were 
males.  
Survival and Risk of Childhood Mortality by Infant Sex  
Kaplan-Meier estimates, hazard ratios, and 95% confidence intervals are 
presented in Table 9. Early childhood survival for males (94.9%) with pulmonary valve 
stenosis was significantly lower (P=0.0116) than females (97.1%). After adjusting for 
covariates, there was no statistically significant difference in early childhood mortality 
between males and females with pulmonary valve stenosis (HR 1.74; 95% CI 0.94-3.21; 
P=0.0768).  
Survival by Maternal Race/Ethnicity and Infant Sex  
Kaplan-Meier estimates for children with pulmonary valve stenosis are presented 
in Table 10, and survival curves are presented in Figure 7. The estimated survival for NH 
black children (94.1%) and Hispanic (95.3%) children was statistically lower than NH 
white children (97.8%), (P=0.034). However, survival was not statistically different for 
NH black males (93.0%), Hispanic males (93.9%), and NH white males (97.2%, 
P=0.1661), or NH black females (94.9%), Hispanic females (96.70%), and NH white 
females (98.2%, P=0.1357).  
Risk of Childhood Mortality by Maternal Race/Ethnicity and Infant Sex 
Hazard ratios and CI for early childhood mortality in children with pulmonary 
valve stenosis are presented in Table 11. NH black children (HR 1.90; CI 0.78-4.62; 
P=0.1565) and Hispanic children (HR 0.89; CI 0.40-1.99; P=0.7806) born with 
pulmonary valve stenosis did not have significantly different risk of early childhood 
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mortality than NH white infants. After stratifying by infant sex and adjusting for 
covariates, early childhood mortality was higher but not statistically significant in NH 
black females (HR 2.34; CI 0.61-8.91; P=0.2138) and lower but not significant in 
Hispanic females (HR 0.66; CI 0.18-2.46; P=0.533) compared to NH white females. 
Differences in males were also not statistically significant: NH black males (HR 1.71; CI 
0.50-5.90; P=0.3962), and Hispanic males (HR 1.19; CI 0.43-3.32; P=0.7424), when 
compared to NH white males.  
DISCUSSION  
We investigated 124 cases of pulmonary valve atresia with HRV, 114 cases of 
pulmonary valve atresia without HRV, and 1323 cases of pulmonary valve stenosis. We 
found that among children with pulmonary valve atresia with HRV, NH blacks had 
higher risk (193%) than NH whites and this risk was the result of NH black males having 
considerably higher risk (363%) of early childhood mortality than NH white males. We 
did not find differences by sex or race/ethnicity for children with pulmonary valve atresia 
without HRV indicating the risk factors for children with this defect differ from those 
affecting children with pulmonary valve atresia with HRV. 
We found that males with pulmonary valve stenosis had lower early childhood 
survival than females with this defect. We also found that early childhood survival for 
children with aortic valve stenosis also varied by maternal race/ethnicity. NH white and 
Hispanic females had fewer deaths in the first year of life than their male counterparts but 
also had more deaths than males in subsequent years. After adjusting for confounders we 
did not find significant differences in early childhood mortality for children with 
pulmonary valve stenosis.  
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We found infant sex and maternal race/ethnicity differences in the pattern of 
survival for pulmonary valve stenosis during study period. However, when considering 
the confounding influence of covariates, we did not find differences in the risk of early 
childhood mortality for this defect. We found infant sex and maternal race/ethnicity 
differences in early childhood mortality for children with pulmonary valve atresia and 
HRV, but had no significant findings for children with pulmonary valve atresia without 
HRV. The variables with most influence on the final regression models for were birth 
weight/gestational age and number of co-occurring defects. 
Sex disparities in early childhood survival indicate genetics may influence 
survival. Our study did not evaluate paternal variables such as paternal race/ethnicity. We 
also did not investigate maternal or paternal environmental factors, family history of 
congenital heart valve defects, or severity of defects. The possibility exists that there are 
unidentified factors that explain the sex disparities in early childhood survival for 
children with congenital pulmonary valve defects. 
Pulmonary valve atresia inclusion criteria for our study were unique: we 
evaluated cases with HRV separately from cases without HRV. As discussed earlier and 
summarized in Table 7, findings of infant sex and maternal race/ethnicity disparities in 
the survival probability or risk of mortality in children with pulmonary valve defects have 
not been reported. However, pulmonary valve atresia has not previously been studied in 
the way we defined our defect, with or without HRV. Therefore, our results may not be 
directly comparable to findings of previous studies. 
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CHAPTER 4: 
DISPARITIES IN SURVIVAL AND MORTALITY AMONG INFANTS WITH 
CONGENITAL TRICUSPID VALVE DEFECTS BY MATERNAL 
RACE/ETHNICITY AND INFANT SEX 
  
ABSTRACT  
Background:  Tricuspid valve atresia is a serious congenital heart defect with poor 
survival outcomes for some infants with this defect. Risk factors that contribute to poor 
survival outcomes in children with tricuspid valve atresia are not well understood. The 
contribution of infant sex and maternal race/ethnicity as risk factors for poor survival has 
not been studied for this defect. 
Methods:  Using data collected by the Texas Birth Defects Registry, we conducted a 
retrospective cohort study of 149 singleton infants born to Hispanic, Non-Hispanic (NH) 
white, and NH black women in Texas between January 1, 1996 and December 31, 2007 
with congenital tricuspid valve atresia. We used Kaplan-Meier survival estimates and 
Cox proportional hazards regression ratios (HR) and 95% confidence intervals (CI) to 
determine, after adjusting for confounders, whether infant sex or maternal race/ethnicity 
affects early childhood survival or risk of mortality for these children.  
Results:  We found that early childhood survival was considerably lower for NH black 
male children (35.7%) and Hispanic males (64.0%) than NH white males (81.0%) with 
tricuspid valve atresia (P=0.0269). After adjusting for covariates, we found that NH black 
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children with tricuspid valve atresia have 239% increased risk of early childhood 
mortality than NH white children (P=0.0062) and the difference in risk was because NH 
black males with tricuspid valve atresia have 423% increased risk of early childhood 
mortality than NH white males (CI 1.33-20.58; P=0.0179).  
Conclusion:  The results of our study demonstrate that male sex and NH black maternal 
race/ethnicity are risk factors for early childhood mortality in children born with tricuspid 
valve atresia. Tricuspid valve atresia is a serious congenital heart defect with poor 
survival outcomes for some children with this defect. Further investigation of the role of 
infant sex and race/ethnicity in prevention and treatment protocols is warranted to better 
understand why this disparity exists and what can be done to improve the outcome for 
NH black male children with this defect. 
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INTRODUCTION  
Birth defects are a primary cause of infant mortality and contribute more than half 
of the reported hospitalization costs associated with birth defects in the United States 
(Russo 2007). In order to improve the health and survival of infants and children, public 
health researchers need to better understand risk factors associated with congenital heart 
defects so that effective prevention and treatment programs can be developed and 
implemented (Botto, Correa et al. 2001; Nembhard, Waller et al. 2001; Cleves, Ghaffar et 
al. 2003; Nembhard, Salemi et al. 2007; Nembhard, Pathak et al. 2008; Nembhard, 
Salemi et al. 2009; Fixler, Nembhard et al. 2010; Nembhard, Salemi et al. 2010). We 
present our investigation of infant sex and maternal race/ethnicity risk factors 
contributing to early childhood survival and risk of mortality for infants born with 
tricuspid valve atresia, in an effort to contribute to the effort to better understand outcome 
disparities. 
Tricuspid Valve Stenosis  
Tricuspid valve stenosis is a narrowing of the valve between the right atrium and 
right ventricle, restricting normal blood circulation. Tricuspid valve stenosis is 
uncommon and little data are available for isolated cases of this defect since tricuspid 
valve stenosis is usually associated with other anomalies, especially right ventricular 
outflow tract obstruction or atresia with secondary hypoplasia of the right ventricle. Also, 
tricuspid valve stenosis is often associated with Ebstein’s anomaly. Since tricuspid valve 
stenosis is rare, our study did not evaluate stenosis of the tricuspid valve. We screened 
TBDR cases identified with BPA Code 746.100, anomalies of the tricuspid valve, as 
tricuspid valve atresia cases for inclusion in our study.  
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Tricuspid Valve Atresia  
Tricuspid valve atresia is the absence of a valve between the right atrium and 
ventricle. Oxygen-depleted blood enters the right atrium but cannot flow to the right 
ventricle where blood would normally be pumped to the lungs. In order for blood to get 
to the lungs, at least one other heart defect must be present (i.e., patent ductus arteriosus; 
atrial septal defect, or ventricular septal defect). Tricuspid valve atresia commonly occurs 
in conjunction with the underdevelopment of the right ventricle, a heart defect referred to 
as hypoplasia of the right ventricle. Tricuspid valve atresia is a serious congenital heart 
defect that can be diagnosed in utero; pregnancy termination may be selected because of 
this diagnosis. Tricuspid valve atresia is also associated with Ebstein’s anomaly. 
Table 14 provides a summary of study findings for tricuspid valve defects. As 
shown in the table, some studies did not differentiate tricuspid valve atresia from 
tricuspid valve stenosis. The prevalence of tricuspid valve atresia per 10,000 live births 
ranges from 0.49 (95% CI 0.35-0.64) to 3.6 (Ferencz, Rubin et al. 1985; Pradat, 
Francannet et al. 2003). Tricuspid valve atresia has been found higher in boys than girls 
with a boy to girl ratio=1.45:1 (Samanek 1994). Racial/ethnic disparity has not been 
reported specifically for the prevalence of tricuspid valve atresia.  
Survival of infants born with tricuspid valve atresia is low. As shown in Table 14, 
the 1-year survival for tricuspid valve atresia has been reported as 46 and 57 percent 
(Samanek 1992; Samanek and Voriskova 1999). There are no reported data for survival 
that differentiate by sex or race/ethnicity. In addition, there are no reported data on the 
risk of mortality for congenital tricuspid valve atresia. 
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METHODS  
Study Design and Data Source  
We conducted a retrospective cohort study of 149 infants with congenital 
tricuspid valve atresia born in Texas between January 1, 1996 and December 31, 2008. 
Data was obtained from the Texas Birth Defects Registry (TBDR), which is maintained 
by the Birth Defects Epidemiology and Surveillance Branch of the Texas Department of 
State Health Services. In the TBDR population-based active surveillance system TBDR 
personnel review medical records to identify infants diagnosed within the first year after 
birth with structural and chromosomal birth defects. The TBDR surveillance began in 
1995, and since 1999 data have been collected for all births in the state of Texas. TBDR 
data are death-to-birth matched by the Texas Vital Statistics Unit using decedent name, 
date of death and date of birth, mother’s first and maiden and/or current last names.  
The TBDR utilizes six-digit birth defect coding that has evolved through British 
Pediatric Association (BPA) extension of the International Classification of Disease, 
ninth revision clinical modification diagnostic codes (ICD-9 codes).  
Study Population  
The study population included all live-born singleton infants with tricuspid valve 
anomalies (BPA Code 746.100) born in Texas between January 1, 1996 and December 
31, 2008 to NH white, NH black, or Hispanic women of any age. As previously stated, 
since tricuspid valve stenosis is rare, our study did not evaluate stenosis of the tricuspid 
valve. We screened TBDR cases identified with BPA Code 746.100, anomalies of the 
tricuspid valve, as tricuspid valve atresia cases for inclusion in our study. Tricuspid valve 
atresia cases with co-occurring heart defects (BPA Codes 745.000 through 747.490) were 
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considered for inclusion in our study (Appendix A). However, cases associated with 
complex defects such as trisomies or syndromes were excluded. For example, tricuspid 
valve atresia associated with Ebstein’s anomaly was not included in our study. All cases 
were reviewed by a pediatric cardiologist (Dr. David E. Fixler, M.D.), and tricuspid valve 
atresia cases were included in our study only if hypoplastic right ventricle (HRV) (BPA 
Code 746.882) was a co-occurring defect. 
Covariates  
We used infant and maternal covariate information obtained by the TBDR from 
birth certificate and medical records. We included infant sex, and maternal race/ethnicity 
based on maternal self-report.  Gestational age categorized as term (≥37 completed 
weeks) or pre-term (<37 weeks) was included; gestational age was based on last 
menstrual period or clinical estimate of gestation from medical records was substituted 
when last menstrual period data were missing. Consistent with published literature, we 
included birth weight categorized as normal (≥2500 grams), low (1500-2499 grams), or 
very low (<1500 grams), as recorded on birth certificates (CDC 1990; Alexander, Kogan 
et al. 2003; Nembhard 2011). Also consistent with literature, gestational age and birth 
weight were included as a combination variable with six categories: <37 weeks and 
<1500 grams; <37 weeks and 1500-2499 grams; <37 weeks and ≥2500 grams; ≥37 weeks 
and <1500 grams; ≥37 weeks and 1500-2499 grams; and ≥37 weeks and ≥2500 grams 
(Bol, Collins et al. 2006; Nembhard 2011). Maternal age categorized as <20 years, 20-29 
years, 30-39 years, and 40+ years and maternal education categorized as high school (12 
years), <high school, or >high school were also included. Our analysis also considered 
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number of recorded birth defects as reported in medical records as an additional 
covariate. 
Data Analysis  
Descriptive statistics were calculated for main study variables and covariates. We 
calculated survival time using date of birth and date of death for deceased infants. When 
TBDR data did not have a date of death recorded, infants were censored at the end of the 
study period, December 31, 2008.  
Early childhood survival was estimated for children with each defect using the 
Kaplan-Meier method. Kaplan-Meier survival curves were computed to compare survival 
estimates by infant sex and maternal race/ethnicity, and tested the difference between the 
curves using the log-rank test.  
Unadjusted and adjusted hazard ratios were calculated for mortality using Cox 
proportional hazard regression models. The adjusted hazard ratios were computed using a 
final regression model developed by backward selection method, removing variables with 
less than 10% effect on the hazard ratio. The created models for infant sex and maternal 
race/ethnicity stratified by sex used females and NH whites as the reference groups. The 
proportional hazards assumption was tested to ensure the assumption was met; we 
inspected the proportionality by including time-dependent covariates in the model and 
testing for their significance. Variables included in the final model were: maternal age, 
maternal education, birth weight/gestational age, and number of defects. Although not all 
variables had a major effect on the adjusted hazard ratios (i.e., changing the hazard ratio 
by 10% or more), all of the variables included in the final model are biologically 
important based on published literature. Results were considered statistically significant 
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if the 95% confidence interval excluded 1 or P<0.05. Calculations were performed using 
SAS 9.2 for Kaplan-Meier survival estimates and Cox proportional hazards regression 
models, and Stata Release 12 for Kaplan-Meier survival plots. 
Protection of Human Subjects  
The study was conducted with the approval of the University of South Florida 
Social and Behavioral Institutional Review Board (IRB) and the Texas Department of 
State Health Services.  
Power and Sample Size  
The formula used to estimate power for this study is an extension of Schoenfeld’s 
sample-size formula for the proportional-hazards regression model, solved for power (1-
β) (Hipwell, Strachan et al. 2000; Shechter, Sharir et al. 2000): 
 
(z1-α/2 + z1-β)
2
  
N   =   _____________________ 
   P (1-R
2) σ2 B2 
 
Where N is the sample size; z1-α/2 and z1-β are standard normal deviates at a two-
sided significance level α and power (1-β); P is the overall event rate or proportion of 
non-censored participants; R
2 is the effect size of covariates on the variable of interest; σ 
is the standard deviation of the variable of interest; and B is the effect size (log of the 
hazard ratio). 
We calculated the power to detect hazard ratios of 1.5 and 3.0; the significance 
level, alpha, for our study was 0.05. Since our associations indicate risk or protective 
exposures, two sided hypotheses were tested. Standard deviation values of 0.5 and 0.7 
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were used to show a range of possibilities; the influence of covariates on the outcome, R
2
 
was estimated at 0.15. Based on the study data, estimates of study power were calculated 
based on three potential scenarios: 1) an event (death) rate of 5%, 2) an event rate of 
10%, and 3) an event rate of 40%.  
The results of these calculations are presented in Appendix B. Since our study 
size was fairly small for some of our stratified groups, our ability to observe statistically 
significant results may be limited. 
RESULTS  
Tricuspid Valve Atresia  
Descriptive statistics for infants born with tricuspid valve atresia are provided in 
Table 15. The total number of cases in our study was 149 and included 45 (30.2%) NH 
white, 28 (18.8%) NH black, and 76 (51%) Hispanic children. Of these, 96 (64.4%) 
children were alive at the end of our study and 53 (35.6%) were deceased. Approximately 
79.2% of surviving children and 52.8% of deceased children were born full term (≥37 
weeks) and at normal birth weight (≥2500 grams); however, of the approximately 28.3% 
of deceased children born pre-term (<37 weeks) and at low (1500-2499) or very low 
(<1500 grams) birth weight, most of these children were Hispanic (66.7%). There were 
approximately as many males (49.7%) as females (50.3%) that had tricuspid valve 
atresia. 
Survival and Risk of Childhood Mortality by Infant Sex  
Kaplan-Meier estimates, hazard ratios and 95% CI are presented in Table 16. 
Early childhood survival for males (63.5%) and females (63.1%) were not different 
(P=0.9023). Also, the risk of early childhood mortality was not different for males than 
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females with tricuspid valve atresia (HR 1.15; 95% CI 0.64-2.04; P=0.6449) after 
adjusting for covariates.  
Survival by Maternal Race/Ethnicity and Infant Sex  
Kaplan-Meier estimates for children with tricuspid valve atresia are presented in 
Table 17, and survival curves are presented in Figure 7. The estimated survival for NH 
black (50.0%) and Hispanic (60.5%) children was not statistically different than NH 
white children (76.9%), (P=0.0615), or for NH black females (64.3%), Hispanic females 
(56.5%), and NH white females (72.6%, P=0.454). However, survival was statistically 
different for NH black males (35.70%) and Hispanic males (64.0%) compared to NH 
white males (81.0%) with tricuspid valve atresia (P=0.0269).  
Risk of Childhood Mortality by Maternal Race/Ethnicity and Infant Sex 
Hazard ratios and CI for early childhood mortality in children with tricuspid valve 
atresia are presented in Table 18. As shown in the table, NH black children with tricuspid 
valve atresia have 239% increased risk of early childhood mortality than NH white 
children (HR 3.39; CI 1.41-8.13; P=0.0062), and this difference was because NH black 
males with tricuspid valve atresia have 423% increased risk of early childhood mortality 
than NH white males (HR 5.23; CI 1.33-20.58; P=0.0179).  
Hispanic children born with pulmonary valve stenosis did not have significantly 
different risk of early childhood mortality than NH white children (HR 1.43; CI 0.66-
3.10; P=0.3689) collectively, or when stratified by sex: Hispanic males (HR 1.33; CI 
0.40-4.41; P=0.6412), Hispanic females (HR 0.67; CI 0.22-2.02; P=0.4753). 
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DISCUSSION  
We investigated 149 cases of tricuspid valve atresia using the Kaplan-Meier 
method with log-rank tests to estimate survival and found that NH black males and 
Hispanic males have significantly lower estimates of study endpoint (December 31, 
2008) survival probability than NH white males with this defect. After adjusting for 
maternal age, maternal education, birth weight/gestational age combinations, and number 
of co-occurring defects covariates in the Cox proportional hazards regression model, we 
observed statistically significant increased risk of early childhood mortality for NH black 
children compared to NH white children, and this was because NH black males have 
423% increased risk of early childhood mortality compared to NH white males. As 
shown on Figure 7, the majority of deaths occur within the first year after birth. 
Literature findings of 1-year survival for cases of tricuspid valve atresia (Table 
14) have been reported at 57% (Samanek 1992) and 46% (Samanek and Voriskova 
1999). Our Kaplan-Meier survival estimates for tricuspid valve atresia demonstrate 
varied survival probabilities: as low as 35.7% (CI 13.0-59.4) in NH black males to 81.0% 
(CI 56.9-92.4) in NH white males.  
We found infant sex and maternal race/ethnicity differences in early childhood 
mortality for children with tricuspid valve atresia, but no significant differences in pattern 
of survival. The variables with most influence on the final regression models for were 
birth weight/gestational age and number of co-occurring defects. 
Tricuspid valve atresia inclusion criteria for our study considered the rare cases of 
tricuspid valve stenosis and were included only if HRV was co-occurring. As such, we 
did not investigate tricuspid valve atresia as an isolated defect since clinically this defect 
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does not occur unless it is part of another malformation of the heart. For this reason, our 
results for tricuspid valve atresia may not be directly comparable to findings of previous 
studies. 
As discussed previously, tricuspid valve atresia is a serious heart defect that can 
be diagnosed in utero and pregnancy termination may be selected because of this 
diagnosis. However, prenatal diagnoses of birth defects have been found to be lower 
among Hispanic and black women (Waller, Pujazon et al. 2000). Our results may be 
biased away from the null as a result of this effect. Our study did not evaluate severity of 
defects, paternal race/ethnicity, maternal or paternal environmental factors, family history 
of congenital heart valve defects, or severity of defects. The possibility exists that there 
are unidentified factors that explain the disparity in early childhood survival for NH black 
males.  
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CHAPTER 5: 
CONCLUSIONS AND RECOMMENDATIONS 
 
The purpose of this study was to determine if the probability of early childhood 
survival or risk of mortality varies by infant sex or maternal race/ethnicity in children 
with congenital heart valve defects in order to expand the existing knowledge of the risk 
factors for these birth defects, and provide public health and clinical practitioners with 
insight for their efforts to implement improvements in the prevention and treatment of 
these defects. We were able to meet our study aims; we demonstrated that there were 
infant sex and maternal racial/ethnic disparities in early childhood survival and risk of 
mortality for children with congenital heart valve defects. 
Our study found that early childhood survival was better for males than females 
with aortic valve atresia and stenosis. However, after adjusting for confounders, we did 
not find statistically significant differences in risk of early childhood mortality for either 
of these defects. We also did not find any differences by race/ethnicity. 
For pulmonary valve stenosis we found that early childhood survival was poorer 
for males than females, and poorer for NH black and Hispanic children than NH white 
children.  
After adjusting for covariates, we determined that NH black children with 
pulmonary valve atresia and HRV have 193% higher risk of early childhood mortality 
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than NH white children; this increased risk was because NH black males with this defect 
have 363% higher risk of early childhood mortality compared to NH white males.  
For tricuspid valve atresia we found poorer survival for NH black males and 
Hispanic males than NH white males. NH black children had 239% increased risk of 
early childhood mortality than NH white children, and NH black males had 423% 
increased risk of early childhood mortality than NH white males with tricuspid valve 
atresia.  
The study had several strengths: 1) the results of our study are highly 
generalizable since the TBDR is a multi-ethnic population-based active surveillance 
system for all births in Texas; 2) our study had a large sample size, data for 2070 infants 
with congenital heart valve defects, providing us with adequate study size to observe 
statistically significant associations by infant sex and maternal race/ethnicity; and 3) 
verified defect diagnoses improved accuracy of the data.  
Our study also had some potential limitations. The numbers of cases of some 
defects (i.e., aortic valve stenosis or pulmonary valve atresia without HRV) may not have 
been large enough to observe associations for three racial/ethnic categories after 
stratifying by infant sex. Perhaps if the study size was larger for these defects, we would 
have observed statistically significant lower risk of mortality in Hispanic females with 
aortic valve stenosis compared to NH white females (P=0.0728), or higher risk of 
mortality in NH black children (P=0.0729) or NH black males (P=0.0570) with 
pulmonary valve atresia and HRV, compared to NH whites. Power and sample size 
calculations (Appendix B) indicate power was limited under some conditions. 
Nonetheless, we observed statistically significant disparities for several defects.  
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Another potential limitation is that the model included co-occurring birth defects 
as a continuous variable, but did not differentiate between protective (e.g., patent ductus 
arteriosus, atrial septal defect, or ventricular septal defect) and deleterious defects. 
Survival for children with some congenital heart valve defects depends on the presence of 
another defect to allow blood to flow through the heart. For example: infants with aortic 
valve atresia may have better chances of survival if patent ductus arteriosus persists; 
pulmonary valve atresia is commonly present in conjunction with ventricular septal 
defect; and infants with tricuspid valve atresia may have better chances of survival if 
patent ductus arteriosus, atrial septal defect, or ventricular septal defect are present. 
Future studies should assess the effects of protective and deleterious co-occurring defects 
when adjusting for covariates.   
We also did not control for the potential confounding effects of initiation of 
prenatal care for mothers. Prenatal detection of congenital heart defects has been found to 
be related to elective termination of pregnancy (Stoll 2002) and varies by race/ethnicity; 
prenatal diagnoses of birth defects is lower among Hispanic and black women (Waller, 
Pujazon et al. 2000). As such, it is possible that more NH white mothers had prenatal 
diagnosis of severe congenital heart defects and elected to terminate the pregnancy more 
often than NH black or Hispanic mothers. As a result, our results may be biased away 
from the null as a result of this effect.  
We did not include geographic variables in our study. Nembhard, Salemi et al. 
(2011) used a rural urban commuting area (RUCA) variable in their regression model for 
determination of hazard ratios. Our data were de-identified, so we did not have access to 
information necessary to include this variable in our regression models.  
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We used case inclusion and exclusion criteria that are rather unique to our study. 
For example, we investigated pulmonary valve atresia with and without HRV. Although 
our criteria allowed us to observe associations for these specific defects, our findings are 
not directly comparable with previous investigations. Further, our pediatric-cardiologist 
verification of defect diagnosis was based on data collected by TBDR personnel, not on 
direct review of clinical records. Our cardiologist review of the data for defect 
verification was conducted by an individual expert, not a panel of experts, which may be 
considered subjective and lacking confirmatory quality assurance of the expert review.  
For the combined birth weight and gestational age covariate in our study, one 
category of this variable (birth weight <1500 grams and gestational age ≥37 weeks) had 
only one infant meeting these criteria; however, on further evaluation we observed that 
the gestational age was reported incorrectly. We calculated gestational age using date of 
birth and date of last menstrual period and found that this infant was less than 37 weeks 
gestation when born. We corrected the data and as a result there were no children meeting 
the criteria of birth weight <1500 grams and gestational age ≥37 weeks in our study. 
Another covariate in our study was self-reported maternal education, and a 
considerable portion of our study population had missing information on this variable. 
We elected to consider “missing” as a variable category in our analysis because there was 
a possibility of systematic differences in the reasons why a mother may choose to not 
report level of education completed. We observed high proportions of deceased children 
for mothers with high school or less than high school education; there was a possibility 
that the missing information could have biased our determinations toward the null in our 
adjusted hazard model. 
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Our study was a population-based retrospective study using TBDR data for all 
children born in Texas between 1996 and 2007. Our findings are highly generalizable 
since our data were population-based; however the racial/ethnic demographics of Texas 
differ from other regions of the United States.  
In conclusion, our investigation identified racial/ethnic associations by infant sex 
that have yet to be reported, and enhanced the findings of previous investigations to 
advance the understanding of the pathogenesis and etiology of congenital heart valve 
defects. Our findings provide a foundation for additional research. We recommend a 
future investigation that includes RUCA variables and considers categories of co-
occurring defects and/or protective vs. deleterious defects. Similar studies using active 
surveillance data for other geographic regions would be useful to determine if disparities 
are present in other demographic populations.  
Disparities in survival probability and risk of mortality indicate genetics may 
contribute to the outcome. Our study did not investigate paternal variables; future 
investigations of the contribution of paternal race/ethnicity, family history of congenital 
heart valve defects, and maternal and paternal environmental exposures may provide 
useful information to further the understanding of the etiology of these defects. 
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APPENDIX A 
TEXAS BIRTH DEFECTS REGISTRY BPA CODES FOR CONGENITAL 
HEART DEFECTS 
 
Table A1. Texas Birth Defects Registry BPA Codes for congenital heart defects 
745 Bulbus Cordis Anomalies and Anomalies of Cardiac Septal Closure   
745.000 Common truncus  
 
Persistent truncus arteriosus 
 
Absent septum between aorta and pulmonary artery 
745.010 Aortic septal defect 
 
Includes: Aortopulmonary window 
 
Excludes: Atrial septal defect  
745.100 Transposition of great vessels, complete (no VSD) 
 
D-transposition with no VSD 
745.110 Transposition of great vessels, incomplete (with VSD) 
 
D-transposition with a VSD 
 
Taussig-Bing syndrome 
 
Transposition with inlet VSD 
 
Transposition with perimembraneous VSD 
 
Excludes: Transposition with muscular VSD 
745.120 Corrected transposition of great vessels, 
 
L-transposition, ventri in version 
 
Ventricular inversion 
 
Excludes: Dextrocardia  
745.180 Other specified transposition of great vessels 
 
Includes: Double outlet right ventricle 
 
Double outlet left ventricle 
745.190 Unspecified transposition of great vessels 
745.200 Tetralogy of Fallot 
 
Diagnosis of Tetralogy of Fallot assumes pulmonary valve defects and right 
ventricular hypertrophy, these defects are not coded separately 
745.300 Single ventricle  
745.400 Ventricular septal defect 
745.400 Roger's disease 
745.410 Eisenmenger's syndrome 
745.420 Gerbode defect 
745.480 Other specified ventricular septal defect (VSD) 
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745.490 Ventricular septal defect (VSD) 
745.500 Ostium secundum type atrial septal defect  
 
Nonclosure of foramen ovale 
 
Patent foramen ovale (PFO) 
745.510 Ostium (septum) secundum defect 
 
Secundum ASD 
 
Fossa ovalis atrial septal defect 
 
Fenestrated ASD 
745.520 Lutembacher's syndrome 
745.580 Other specified atrial septal defect 
745.590 ASD (atrial septal defect) 
 
Auricular septal defect 
 
Partial foramen ovale 
 
PFO vs. ASD  
 
PFO vs secundum ASD  
745.600 Endocardial cushion defects  
 
Ostium primum defects 
 
Primum ASD 
745.610  Single common atrium, cor triloculare biventriculare 
745.630  Common atrioventricular canal 1 
 
Includes: Complete AV canal defect 1 
745.680 Other specified cushion defect 
745.690 Endocardial cushion defect, NOS 
745.700 Cor biloculare   
745.800 Other specified defects of septal closure  
745.900 Unspecified defect of septal closure 
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746 Other Congenital Anomalies of Heart 
746.000 Anomalies of pulmonary valve 
 
Atresia, hypoplasia of pulmonary valve 
 
Absent pulmonary valve 
 
See 746.995 if valve is not specified (e.g., "pulmonary atresia") 
746.010 Stenosis of pulmonary valve 
 
Small pulmonary valve 
 
See 746.995 if valve not specified (e.g., "pulmonary stenosis") 
 
Excludes: Pulmonary infundibular stenosis  
746.020 Pulmonary valve insufficiency or regurgitation, congenital 
746.080 Other specified anomalies of pulmonary valve 
 
Thickened pulmonary valve 
 
Dysplastic pulmonary valve 
 
Enlarged pulmonary valve 
 
Dilated pulmonary valve 
 
Bicuspid pulmonary valve 
 
Redundant pulmonary valve 
 
Dysmorphic pulmonary valve 
 
Excludes: Pulmonary infundibular 
 
Stenosis (Use 746.830) 
746.090 Unspecified anomaly of pulmonary valve 
746.100 Anomalies of the tricuspid valve 
 
Tricuspid atresia, stenosis, or hypoplasia 
 
Right atrioventricular (AV) atresia, stenosis, or hypoplasia 
 
Bicuspid right atrioventricular (AV) valve 
 
Bicuspid tricuspid valve 
 
Cleft right atrioventricular (AV) valve 
 
Cleft tricuspid valve 
 
Dysplastic right atrioventricular (AV) valve 
 
Dysplastic tricuspid valve 
 
Small right atrioventricular (AV) valve 
 
Small tricuspid valve 
746.105 Tricuspid valve insufficiency or regurgitation, congenital 
 
Right atrioventricular (AV) valve insufficiency or regurgitation, congenital 
 
Tricuspid valve incompetence 
 
Excludes: Ebstein's anomaly  
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746.180 Other anomalies of the tricuspid valve 
 
Abnormal tricuspid valve 
 
Dilated right atrioventricular (AV) valve 
 
Dilated tricuspid valve 
 
Enlarged right atrioventricular (AV) valve 
 
Enlarged tricuspid valve 
 
Redundant tricuspid valve 
 
Right atrioventricular (AV) valve aneurysm 
 
Thickened right atrioventricular (AV) valve 
 
Thickened tricuspid valve 
 
Tricuspid valve aneurysm 
 
Tricuspid valve prolapse 
746.200 Ebstein's anomaly 
746.300 Congenital stenosis of aortic valve 
 
Includes: Congenital aortic stenosis 
 
Subvalvular aortic stenosis 
 
Small aortic valve 
 
Excludes: Supravalvular aortic stenosis  
746.400 Congenital insufficiency of aortic valve  
 
Aortic valve insufficiency or regurgitation, congenital bicuspid aortic valve 
 
Aortic valve incompetence 
746.480 Other specified anomalies of the aortic valves 
 
Includes: Aortic valve atresia 
 
Aortic annulus defects 
 
Hypoplastic aortic valve 
 
Dysplastic aortic valve 
 
Thickened aortic valve 
 
Absent aortic valve 
 
Dysmorphic aortic valve 
 
Quadricuspid aortic valve 
 
Narrow aortic annulus 
 
Excludes: Supravalvular aortic stenosis  
746.490 Unspecified anomalies of the aortic valves 
 
Abnormal aortic valve 
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746.500 Congenital mitral stenosis  
 
Congenital left atrioventricular (AV) stenosis 
 
Thickened mitral valve 
 
Thickened left atrioventricular (AV) valve 
746.505 Absence, atresia, or hypoplasia of mitral valve 
 
Abnormal mitral valve 
 
Absence, atresia, or hypoplasia of left atrioventricular (AV) valve 
 
Cleft left atrioventricular (AV) valve 
 
Cleft mitral valve 
 
Double orifice mitral valve 
 
Dysmorphic mitral valve 
 
Dysplastic left atrioventricular (AV) valve 
 
Dysplastic mitral valve 
 
Left atrioventricular (AV) valve prolapse 
 
Mitral valve anomaly 
 
Mitral valve prolapse 
 
Parachute left atrioventricular (AV) valve 
 
Parachute mitral valve 
746.600 Mitral valve insufficiency or regurgitation, congenital 
 
Left atrioventricular (AV) valve insufficiency or regurgitation, congenital 
746.700 Hypoplastic left heart syndrome   
 
Diagnosis of hypoplastic left heart syndrome assumes the following 
diagnoses: 
 
Hypoplastic left ventricle - 746.881 
 
Mitral valve anomalies - 746.5 and 746.6 
 
Aortic valve anomalies - 746.3 and 746.4 
 
Atresia or hypoplasia of the ascending aorta - 747.210 
 
When mitral valve or aortic valve are absent/atretic, those defects are 
diagnosed separately. 
 
Atresia, or marked hypoplasia of the ascending aorta and defective 
development of 
 
the left ventricle (with mitral valve involvement) 
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746.800 Other specified anomalies of the heart  
 
Dextrocardia without situs inversus (situs solitus) 
 
Dextrocardia with no mention of situs inversus 
 
Excludes: Dextrocardia with situs inversus (Use 759.300) 
 
Dextrocardia with left congenital diaphragmatic hernia 
746.820 Cor triatriatum 
746.830 Pulmonary infundibular (subvalvular) stenosis 
746.840 Trilogy of Fallot 
746.850 Anomalies of pericardium 
746.860 Anomalies of myocardium 
 
Cardiomegaly, congenital, 
 
Cardiomyopathy, congenital 
 
Cardiomyopathy, hypertrophic 
 
Rhabdomyoma (heart) 
 
Ventricular hypertrophy, bilateral 2 
 
Ventricular septal thickening 
 
Ventricular septal hypertrophy 
 
Excludes: Ventricular hypertrophy, unilateral (Use 746.886) 
746.870 Congenital heart block 
746.880 Other specified anomalies of heart 
 
Includes: Ectopia (ectopic) cordis (mesocardia), conduction defects, 
 
Shone’s complex 
 
Tumor of the heart 
 
Hypoplastic heart 
 
Long Q-T syndrome 
 
Left ventricular outflow tract obstruction  
 
Right ventricular outflow tract obstruction  
746.881 Hypoplastic left ventricle 
 
Excludes: Hypoplastic left heart syndrome  
746.882 Hypoplastic right heart (ventricle) 
 
Uhl's disease 
746.883 Hypoplastic ventricle 
746.885 Anomalies of coronary artery or sinus 
 
Dilated coronary sinus  
 
Excludes: Dilated coronary sinus when there is a left superior vena cava 
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746.886 Ventricular hypertrophy, unilateral (right or left) 
 
Excludes: Ventricular hypertrophy, bilateral  
746.887 746.887 Other defects of the atria 
 
Hypoplastic atrium 
 
Excludes: Congenital Wolfe-Parkinson-White  
 
Rhythm anomalies 
746.900 Unspecified anomalies of heart   
 
Unspecified anomalies of heart valves 
 
Truncal valve 
 
Truncal valve insufficiency and regurgitation 
 
Truncal valve stenosis 
 
Narrow truncal valve 
 
Single atrioventricular valve 
 
Single atrioventricular valve insufficiency and regurgitation 
746.910 Anomalous bands of heart 
746.920 Acyanotic congenital heart disease, NOS 
746.930 Cyanotic congenital heart disease, NOS 
 
Blue baby 
746.990 Unspecified anomaly of heart: 
 
Includes: Congenital heart disease (CHD) 
746.995  "Pulmonic" or "pulmonary" atresia, stenosis, or hypoplasia, NOS (no 
mention of valve or artery) 
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747 Other Congenital Anomalies of Circulatory System 
747.000 Patent ductus arteriosus  
747.100 Coarctation of aorta  
 
Preductal (proximal) coarctation of aorta 
747.110 Postductal (distal) coarctation of aorta 
747.090 Unspecified coarctation of aorta 
 
Juxtaductal coarctation of aorta 
747.200 Other anomalies of aorta  
 
Atresia of aorta 
 
Absence of aorta 
 
Atrophy of aorta 
 
Pseudotruncus arteriosus 
 
Stenosis of aorta 
747.210 Hypoplasia of aorta 
 
Tubular hypoplasia of aorta 
 
Small aorta 
 
Narrowing of aorta 
 
Proximal distal transverse arch hypoplasia 
 
Narrow aortic isthmus 
 
Hypoplastic aortic arch 
747.215  Interrupted aortic arch 
747.220 Supra-aortic stenosis (supravalvular) 
 
Excludes: Aortic valve stenosis, congenital (See 746.300) 
747.230 Persistent right aortic arch 
747.240 Aneurysm of sinus of Valsalva 
747.250 Vascular ring (aorta) 
 
Double aortic arch 
 
Includes: Vascular ring compression of trachea 
747.260 Overriding aorta 
 
Dextroposition of aorta 
 
Malaligned aorta 
747.270 Congenital aneurysm of aorta 
 
Congenital dilatation of aorta 
 
Enlarged aorta 
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747.280  Other specified anomalies of aorta 
 
Collateral vessel involving aorta 1 
 
Pseudocoarctation of aorta 
 
Elongation of aorta 
747.290 Unspecified anomalies of aorta 
747.300 Anomalies of pulmonary artery  
 
Pulmonary artery atresia, absence, or agenesis 
 
Use 746.995 if artery or valve is not specified 
747.310 Pulmonary artery atresia with septal defect 
747.320 Pulmonary artery stenosis 
 
Supravalvular pulmonary stenosis 
 
Pulmonary artery narrowing 
 
Use 746.995 if artery or valve is not specified 
747.325 Peripheral pulmonary artery stenosis 
 
Includes: peripheral pulmonic stenosis (PPS)  
 
pulmonary artery branch stenosis  
 
peripheral pulmonic stenosis (PPS) murmur 
747.330 Aneurysm of pulmonary artery 
 
Dilatation of pulmonary artery 
 
Enlarged pulmonary artery 
747.340 Pulmonary arteriovenous malformation or aneurysm 
747.380 Other specified anomaly of pulmonary artery 
 
Includes: Pulmonary artery hypoplasia 
 
Small pulmonary artery 
 
Overriding pulmonary artery 
 
Collateral vessel involving pulmonary artery (and not aorta) 1 
 
Pulmonary vascular or artery sling 
747.390 Unspecified anomaly of pulmonary artery 
747.400 Anomalies of great veins  
 
Stenosis of vena cava (inferior or superior) 
 
Small vena cava (inferior or superior) 
747.410 Persistent left superior vena cava 
 
Bilateral superior vena cava 
747.420  (TAPVR) Total anomalous pulmonary venous return 
747.430 Partial anomalous pulmonary venous return 
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747.440 Anomalous portal vein termination 
747.450 Portal vein - hepatic artery fistula 
747.480 Other specified anomalies of great veins 
 
Enlarged vena cava (inferior or superior) 
 
Pulmonary vein atresia 
 
Pulmonary vein stenosis 
 
Dilated vena cava (inferior or superior) 
 
Absent vena cava (inferior or superior) 
 
Interrupted inferior vena cava 
 
Bilateral inferior vena cava 
 
Anomalous pulmonary venous return – total/partial not specified 
 
Small pulmonary veins 
 
Excludes: Absent left superior vena cava (LSVC) which would be normal 
747.490 Unspecified anomalies of great veins 
747.500 Absence or hypoplasia of umbilical artery 
 
Single umbilical artery 
 
Two-vessel cord 
 
Umbilical artery hypoplasia 
747.600 Other anomalies of peripheral vascular system   
 
Stenosis of renal artery 
747.610 Other anomalies of renal artery 
 
Absent renal artery 
747.620 Arteriovenous malformation (peripheral) 
 
Excludes: Pulmonary (747.340) 
 
Cerebral (747.800) 
 
Retinal (743.510) 
747.630 Congenital phlebectasia 
 
Congenital varix 
747.640 Other anomalies of peripheral arteries 
 
Includes: Aberrant subclavian artery 
 
Common brachiocephalic trunk 
 
Aberrant innominate artery 
 
Absent carotid artery 
 
Anomalous carotid artery 
  
105 
 
Table A1. Texas Birth Defects Registry BPA Codes for congenital heart defects 
 
747.650 Other anomalies of peripheral veins 
 
Hemiazygos vein anomalies 
 
Hypoplastic innominate vein 
 
Hypoplastic jugular vein 
 
Hepatic vein stenosis 
747.680 Other anomalies of peripheral vascular system 
 
Includes: Four vessel umbilical cord 
747.690 Unspecified anomalies of peripheral vascular system 
747.800 Other specified anomalies of circulatory system  
 
Arteriovenous (malformation) aneurysm of brain 
747.810 Other anomalies of cerebral vessels 
 
Includes: Anomalies of Vein of Galen 
747.880 Other specified anomalies of circulatory system 
 
Endothelial vessel 
 
Collateral vessel (not involving aorta or pulmonary artery) 1 
 
Excludes: Congenital aneurysm: 
 
Coronary (746.880) 
 
Peripheral (747.640) 
 
Pulmonary (747.330) 
 
Retinal (743.510) 
 
Ruptured cerebral arteriovenous 
 
Aneurysm 
 
Ruptured cerebral aneurysm 
747.900 Unspecified anomalies of circulatory system  
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APPENDIX B: 
ESTIMATED POWER CALCULATIONS AND ASSUMPTIONS 
The formula used to estimate power for this study is an extension of Schoenfeld’s 
sample-size formula for the proportional-hazards regression model, solved for power (1-
β) (Hipwell, Strachan et al. 2000; Shechter, Sharir et al. 2000). We performed power 
calculations using Power Analysis and Sample Size (PASS) software by NCSS (Kaushik, 
Leon et al. 2000).  
(z1-α/2 + z1-β)
2
  
N   =   _____________________ 
   P (1-R
2) σ2 B2 
Where N is the sample size; z1-α/2 and z1-β are standard normal deviates at a two-
sided significance level α and power (1-β); P is the overall event rate or proportion of 
non-censored participants; R
2.is the effect size of covariates on the variable of interest; σ 
is the standard deviation of the variable of interest; and B is the effect size (log of the 
hazard ratio). 
In order to calculate an estimate of power for this study, several assumptions have 
been used to select parameter values for inclusion in the formula. Our study was 
conducted using TBDR data for 2070 singleton infants born between January 1, 1996 and 
December 31, 2007 with congenital heart valve defects.  We found that approximately 
48.4% of our cases were Hispanic (1001), 39.8% were non-Hispanic white (824), and 
11.8% were non-Hispanic black (245); our study included 219 infants with aortic valve 
atresia, 300 with had aortic valve stenosis, 124 with pulmonary valve atresia and HRV, 
114 with pulmonary valve atresia without HRV, 1323 with pulmonary valve stenosis, and 
149 with tricuspid valve atresia.  
We calculated the power to detect hazard ratios of 1.5 and 3.0; the significance 
level, alpha, for our study was 0.05. Since our associations indicate risk or protective 
exposures, two sided hypotheses were tested.   
We calculated power using standard deviation values of 0.5 and 0.7 to show a 
range of possibilities, and assumed that the outcome was influenced by covariates such 
that the value of R2 was assumed to be 0.15. These values were selected as moderate 
points from a range of potential values. 
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Based on the study data, estimates of study power were calculated based on three 
potential scenarios: 1) an event (death) rate of 5%, 2) an event rate of 10%, and 3) an 
event rate of 40%.  
The results of these calculations are presented in Table B1. As shown in the table, 
estimated study power varies considerably for the various scenarios of our study. 
Although our study size was fairly small for some of our stratified groups, we were able 
to observe statistically significant results although the power to detect these results may 
have been limited.  
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Table B1. Estimated power for various sample sizes, standard deviations, and event rates 
     
R-Squared 
  
 
Sample Reg. S.D. Event X1 vs Two- 
 
 
Size Coef. of X1 Rate Other X's Sided 
 Power (N) (B) (SD) (P) (R2) Alpha Beta 
0.03811 20 0.4055 0.5 0.05 0.15 0.05 0.96189 
0.04802 50 0.4055 0.5 0.05 0.15 0.05 0.95198 
0.06154 100 0.4055 0.5 0.05 0.15 0.05 0.93846 
0.07304 20 1.0986 0.5 0.05 0.15 0.05 0.92696 
0.12318 50 1.0986 0.5 0.05 0.15 0.05 0.87682 
0.20396 100 1.0986 0.5 0.05 0.15 0.05 0.79604 
0.04498 20 0.4055 0.5 0.1 0.15 0.05 0.95502 
0.06154 50 0.4055 0.5 0.1 0.15 0.05 0.93846 
0.08552 100 0.4055 0.5 0.1 0.15 0.05 0.91448 
0.10679 20 1.0986 0.5 0.1 0.15 0.05 0.89321 
0.20396 50 1.0986 0.5 0.1 0.15 0.05 0.79604 
0.35999 100 1.0986 0.5 0.1 0.15 0.05 0.64001 
0.07618 20 0.4055 0.5 0.4 0.15 0.05 0.92382 
0.13051 50 0.4055 0.5 0.4 0.15 0.05 0.86949 
0.21836 100 0.4055 0.5 0.4 0.15 0.05 0.78164 
0.2989 20 1.0986 0.5 0.4 0.15 0.05 0.7011 
0.61976 50 1.0986 0.5 0.4 0.15 0.05 0.38024 
0.89306 100 1.0986 0.5 0.4 0.15 0.05 0.10694 
0.04473 20 0.4055 0.7 0.05 0.15 0.05 0.95527 
0.06103 50 0.4055 0.7 0.05 0.15 0.05 0.93897 
0.0846 100 0.4055 0.7 0.05 0.15 0.05 0.9154 
0.10547 20 1.0986 0.7 0.05 0.15 0.05 0.89453 
0.20075 50 1.0986 0.7 0.05 0.15 0.05 0.79925 
0.35398 100 1.0986 0.7 0.05 0.15 0.05 0.64602 
0.05593 20 0.4055 0.7 0.1 0.15 0.05 0.94407 
0.0846 50 0.4055 0.7 0.1 0.15 0.05 0.9154 
0.12873 100 0.4055 0.7 0.1 0.15 0.05 0.87127 
0.16921 20 1.0986 0.7 0.1 0.15 0.05 0.83079 
0.35398 50 1.0986 0.7 0.1 0.15 0.05 0.64602 
0.61106 100 1.0986 0.7 0.1 0.15 0.05 0.38894 
0.11128 20 0.4055 0.7 0.4 0.15 0.05 0.88872 
0.21487 50 0.4055 0.7 0.4 0.15 0.05 0.78513 
0.38024 100 0.4055 0.7 0.4 0.15 0.05 0.61976 
0.5181 20 1.0986 0.7 0.4 0.15 0.05 0.4819 
0.88701 50 1.0986 0.7 0.4 0.15 0.05 0.11299 
0.9942 100 1.0986 0.7 0.4 0.15 0.05 0.0058 
 
